Allan Garland, MD, MA - University of Manitoba · 2020-04-08 · Allan Garland, MD, MA Page 3 of 31 2000 - 2005 Clinical Associate Professor, Rutgers University College of Nursing,

CURRICULUM VITA

Name: Allan Garland, MD, MA Address: Health Sciences Center 820 Sherbrook Street -- GF 222 Winnipeg, Manitoba, Canada R3A 1R9 phone: 204-787-1198 / email: [email protected] Date of Birth: November 16, 1955 Place of Birth: Detroit, Michigan, USA

Contents Education ............................................................................................................................................ 2 Postdoctoral Training ........................................................................................................................... 2

Internship and Residency 2 Fellowship 2

Medical Certification and Recertification .............................................................................................. 2 Medical Licensure ................................................................................................................................ 2 Research-related Certification ............................................................................................................. 2 Academic Appointments ...................................................................................................................... 2 Leadership Appointments .................................................................................................................... 3 Other Appointments ............................................................................................................................. 3 Peer Review Activities ......................................................................................................................... 3

Grants 3 Journals 4

Editorial Positions/Boards .................................................................................................................... 5 Committee Memberships, National and International........................................................................... 5 Committee Memberships, Local (selected) .......................................................................................... 5 Awards and Honors ............................................................................................................................. 6 Memberships in Professional Societies ............................................................................................... 7 Teaching Experience, Nonmedical ...................................................................................................... 7 Professional Activities .......................................................................................................................... 7

National and International 7 Local and Regional 10

Bibliography: Summary ...................................................................................................................... 13 Original Research Papers 13 Original Papers Under Review 18 Papers in Preparation 19 Government Reports 19 Review Articles 19 Invited Editorials 19 Correspondence 19 Conference presentations, Abstracts 20 Book Chapters 26 Electronic Media 26 Software 26

Trainee Research Supervision ........................................................................................................... 26 Research Funding Summary (non-profit funding agencies only) ....................................................... 27 Current Grant Support ....................................................................................................................... 27 Past Grant Support ............................................................................................................................ 28 Grant Support Applied For ................................................................................................................. 30 Past Contract Support ....................................................................................................................... 30

Allan Garland, MD, MA Page 2 of 31

Education 1977 B.S. University of Michigan (Physics, with High Honors) 1978 MA Harvard University (Physics) 1986 MD University of Chicago Pritzker School of Medicine

Postdoctoral Training Internship and Residency

1986 - 1987 Intern in Internal Medicine, University of Iowa Hospitals and Clinics 1987 - 1989 Resident in Internal Medicine, University of Chicago Hospitals and Clinics

Fellowship

1989 - 1993 Fellow in Pulmonary and Critical Care Medicine, University of Chicago Hospitals and Clinics

Medical Certification and Recertification 1989 - Diplomate in Internal Medicine, American Board of Internal Medicine, Registration

No. 124455 1992 - 2002 Diplomate in Pulmonary Medicine, American Board of Internal Medicine, Registration No. 1244552 2002 - 2012 Recertification in Pulmonary Medicine, American Board of Internal Medicine, Registration No. 1244552 1993 - 2003 Diplomate in Critical Care Medicine, American Board of Internal Medicine,

Registration No. 124455 2003 - 2013 Recertification in Critical Care Medicine, American Board of Internal Medicine,

Registration No. 1244552

Medical Licensure 1987 - 1996 Illinois License, Physician and Surgeon, Registration No. 036-076133 1993 - 2001 New Jersey License, Physician, Registration No. MA-62350 2001 - 2009 Ohio License, Physician, Registration No. 35-07-9936-G 2007 - Manitoba License, Physician, Registration No. 16-429

Research-related Certification 2013 National Institutes of Health (NIH) Office of Extramural Research Web-based training

course Protecting Human Research Participants. (Certification #1206642) 2019 CIHR institute of Gender and Health Core Competency Modeule for Sex and Gender in

the Analysis of Secondary Data for Human Participants

Academic Appointments 1993 - 2001 Assistant Professor of Medicine, University of Medicine and Dentistry of New

Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey


2000 - 2005 Clinical Associate Professor, Rutgers University College of Nursing, Newark, New Jersey

2001 Associate Professor of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey

2002 - 2007 Associate Professor of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio

2003 - 2007 Senior Scholar, Case Western Reserve University School of Medicine - MetroHealth System Center for Health Care Research & Policy

2007 - 2015 Associate Professor of Medicine, University of Manitoba, Winnipeg, Manitoba 2007 - 2015 Associate Professor of Community Health Sciences, University of Manitoba,

Winnipeg, Manitoba 2008 - Adjunct Scientist, Manitoba Centre for Health Policy, Winnipeg, Manitoba 2015 - Professor of Medicine, University of Manitoba, Winnipeg, Manitoba 2015 - Professor of Community Health Sciences, University of Manitoba, Winnipeg,

Manitoba

Leadership Appointments 1993 - 2001 Director, Medical Intensive Care Unit, Robert Wood Johnson University Hospital,

New Brunswick, New Jersey 1994 - 1997 Director, Respiratory Care Unit, Robert Wood Johnson University Hospital, New

Brunswick, New Jersey 1996 - 1998 Director, Respiratory Services Department, Robert Wood Johnson University

Hospital, New Brunswick, New Jersey 1999 - 2001 Director, South Building Medical Unit, Robert Wood Johnson University Hospital,

New Brunswick, New Jersey 2002 - 2007 Director, Medical Intensive Care Unit, MetroHealth Medical Center,

Cleveland, Ohio 2004 - 2007 Co-Director, Department of Medicine Residency Procedure Service, MetroHealth

Medical Center, Cleveland, Ohio 2012 - Co-Head, Section of Critical Care Medicine, University of Manitoba, Winnnipeg,

Manitoba

Other Appointments 2016 - Senior Decision Support Analyst, Winnipeg Regional Health Authority

Peer Review Activities Grants

2008 Alberta Heritage Foundation for Medical Research, external reviewer 2010 Manitoba Health Research Council 2011 Manitoba Health Research Council 2011 Physicians’ Services Foundation, Toronto, external reviewer 2012 Manitoba Health Research Council 2013 Alberta Innovates – Health Solutions, external reviewer 2016 Nova Scotia Health Authority Research Fund, external reviewer 2016 Canadian Institutes for Health Research, Project Scheme Competition


2017 Research Manitoba 2017 Canadian Institutes for Health Research, Fall Project Scheme Competition, Health

Services Evaluation & Interventions Research Committee 1, reviewer 2017 French Ministry for Solidarity and Health, Paris, external expert grant reviewer 2017 Physicians’ Services Foundation, Toronto, external reviewer 2018 Canadian Institutes for Health Research, SPOR Innovative Clinical Trial Multi-Year

Grant, ad-hoc reviewer 2018 Canadian Institutes for Health Research, Fall Project Scheme Competition, Health

Services Evaluation & Interventions Research Committee 2, reviewer 2018 Canadian Institutes for Health Research, Spring Project Scheme Competition,

Health Services Evaluation & Interventions Research Committee 3, external reviewer

Journals

Invited Reviewer, American Journal of Critical Care Invited Reviewer, American Review of Respiratory and Critical Care Medicine Invited Reviewer, Annals of Epidemiology Invited Reviewer, Annals of Intensive Care Invited Reviewer, Annals of Internal Medicine

- Rated in top 10% of reviewers in 2009 - Rated “Top grade” of reviewers in 2010, 2012, and 2018

Invited Reviewer, Annals of The American Thoracic Society Invited Reviewer, Archives of Physical Medicine and Rehabilitation Invited Reviewer, BMC Anesthesiology Invited Reviewer, BMC Health Services Research Invited Reviewer, BMC Medical Research Methodology Invited Reviewer, BMC Research Notes Invited Reviewer, BMJ Invited Reviewer, British Journal of Pharmacology Invited Reviewer, Canadian Journal of Respiratory, Critical Care and Sleep Medicine Invited Reviewer, CMAJ Open Invited Reviewer, Canadian Respiratory Journal Invited Reviewer, Chest Invited Reviewer, Clinical Epidemiology Invited Reviewer, Critical Care Invited Reviewer, Critical Care Medicine Invited Reviewer, European Respiratory Journal Invited Reviewer, Experimental Lung Research Invited Reviewer, Intensive Care Medicine Invited Reviewer, JAMA Internal Medicine Invited Reviewer, Journal of Critical Care Invited Reviewer, Journal of General Internal Medicine Invited Reviewer, Journal of Hospital Medicine Invited Reviewer, Life Sciences Invited Reviewer, Lung Invited Reviewer, Medical Decision Making Invited Reviewer, PLOS One


Invited Reviewer, Pulmonary Pharmacology Invited Reviewer, Thorax

Editorial Positions/Boards 1998 - 2005 CHEST, Critical Care Reviews Department Editor 1998 - 2005 CHEST, Editorial Board Member

Committee Memberships, National and International 2009 - 2010 American Thoracic Society, Member, 2010 International Conference Program

Committee 2010 - 2011 American Thoracic Society, Member, 2011 International Conference Program

Committee 2011 - 2012 American Thoracic Society, Member, 2012 International Conference Program

Committee 2013 - 2015 Scientific Advisory Committee, Canadian Frailty Network (CIHR National Centre of

Excellence) 2014 - 2018 Member, Research Steering Committee, “ICU Capacity Strain”. Grant funded by

Alberta Innovates-Health Solutions. 2015 - 2016 Canadian Institute for Health Information, Critical Care Consulting Group. 2015 - Research Management Committee, Canadian Frailty Network (CIHR National

Centre of Excellence)

Committee Memberships, Local (selected) 2001 MetroHealth Medical Center, Antibiotic Subcommittee of Pharmacy &

Therapeutics Committee 2002 - 2007 MetroHealth Medical Center, Medical ICU Quality Circle (chair) 2002 - 2007 MetroHealth Medical Center, Intern Selection Committee 2002 - 2007 MetroHealth Medical Center, Medical ICU Nursing Quality Circle 2002 - 2007 MetroHealth Medical Center, Critical Care Committee 2003 - 2005 MetroHealth Medical Center, Inpatient Catalyst Committee 2003 MetroHealth Medical Center, Inpatient Throughput Subcommittee of Inpatient

Catalyst Committee 2004 - 2007 MetroHealth Medical Center, Clinical Research Center Protocol Committee 2004 - 2005 MetroHealth Medical Center, Patient Safety Committee 2005 - 2007 Case Western Reserve University School of Medicine, Module 4 Curriculum

Redesign Committee 2008 - Department of Medicine Database Steering Committee, University of Manitoba 2009 - 2010 Search Committee for Biostatistician in Department of Medicine, University of

Manitoba (chair) 2010 Search Committee for Critical Care Program Section Head and Medical Director,

Winnipeg Regional Health Authority. 2011 University of Manitoba School of Medicine, Curriculum Renewal Task Group on

Health Care Systems and Quality (co-chair) 2011 - 2013 University of Manitoba School of Medicine, Curriculum Renewal Steering

Committee


2012 Search Committee for Director of Organ Donation Organization, Winnipeg Regional Health Authority

2012 - Executive Committee, Department of Medicine, University of Manitoba 2012 - Winnipeg Regional Health Authority, Adult Critical Care Program Outcomes

Improvement Steering Committee 2012 - 2017 University of Manitoba Section of Critical Care Medicine, Research Committee

(chair) 2016- Vice-Chair, General Medicine Product Review, Evaluation and Standardization

Committee, Winnipeg Regional Health Authority 2016- Vascular Access Working Group of the Product Review, Evaluation and

Standardization Committee, Winnipeg Regional Health Authority (chair) 2017- Rehabilitation Equipment Working Group of the Product Review, Evaluation and

Standardization Committee, Winnipeg Regional Health Authority (chair) 6/19/2017 Chair, Ph.D. Oral Defence Committee, Kumar Alok Pathak, Department of Human

Anatomy and Cell Science, University of Manitoba. 12/11/2017 Chair, M.Sc. Oral Defence Committee, Lindsey Dahl, Department Community

Health Sciences, University of Manitoba. 2017-2018 Clinical Supply Disruption Mitigation Committee, Manitoba Health 2018 - Research and Faculty Development Committee, Department of Internal Medicine,

University of Manitoba 2019 - Member, Core Internal Medicine Residency Review Committee, University of

Manitoba, Winnipeg, Manitoba

Awards and Honors 1977 Phi Beta Kappa, National Honorary Society 1977 University of Michigan Extraordinary Merit Award 1977-1978 Harvard University Graduate Fellowship 1978-1979 Smithsonian Institution Predoctoral Fellowship 1989-1991 American Lung Association Research Fellowship 1994 Outstanding Teaching Attending Award, Robert Wood Johnson Medical School,

Department of Medicine 1995 Outstanding Teaching Attending Award, Robert Wood Johnson Medical School,




Department of Medicine 1998 Included in Best Doctors in America, 1998, Pulmonary & Critical Care Medicine,

Best Doctors, Inc., Aiken, SC 1998 Included in The Best Doctors in New Jersey, New Jersey Monthly, November 1998 1999 Excellence in Teaching Award, Robert Wood Johnson Medical School, Department

of Medicine 2001 Excellence in Teaching Award, Robert Wood Johnson Medical School, Department

of Medicine


2002 Included in Best Doctors in America, 2001-2002, Pulmonary & Critical Care Medicine, Best Doctors, Inc., Aiken, SC

2002 Included in The Best Doctors in Cleveland, Cleveland Magazine, August 2002 2002 Alfred Sofer Award for Editorial Excellence, American College of Chest Physicians 2004 Included in Best Doctors in America, 2003-2004, Pulmonary & Critical Care

Medicine, Best Doctors, Inc., Aiken, SC 2004 Included in The Best Doctors in Cleveland, Cleveland Magazine, March 2004 2005 Included in Guide to America’s Top Physicians 2nd edition, Consumers’ Research

Council of America, Washington, D.C. 2005 Richard J. Blinkhorn Faculty Teaching Award, MetroHealth Medical Center,

Department of Medicine 2006 Included in Best Doctors in America, 2004-2005, Pulmonary & Critical Care

Medicine, Best Doctors, Inc., Aiken, SC 2006 Included in The Best Doctors in Cleveland, Cleveland Magazine, March 2006 2007 Included in The Best Doctors in Cleveland, Cleveland Magazine, March 2007 2007 Teaching Excellence Award, MetroHealth Medical Center, Department of Medicine 2007 Chairman’s Award, MetroHealth Medical Center, Department of Medicine 2007 Included in Best Doctors in America, 2007-2008, Pulmonary & Critical Care

Medicine, Best Doctors, Inc., Aiken, SC 2017 Manitoba Medical Students’ Association, nominee for Med 1 Pre-clerkship

Inspiration award. 2017 Manitoba Medical Students’ Association, nominee for Med 1 Pre-clerkship Best

Teaching in a Small Group Setting award. 2018 Manitoba Medical Students’ Association, nominee for Med 2 Pre-clerkship

Inspiration award. 2018 Manitoba Medical Students’ Association, nominee for Med 2 Pre-clerkship

Teaching in a Small Group Setting award. 2018 Manitoba Medical Students’ Association, nominee for Med 2 Pre-clerkship

Innovation award.

Memberships in Professional Societies 1987 - 1990 Associate, American College of Physicians 1989 - 1993 Associate, American Thoracic Society 1990 - 1996 Member, American College of Physicians 1994 - Member, American Thoracic Society 1994 - 2001 Member, New Jersey Thoracic Society 1998 - 2001 Member, Cancer Institute of New Jersey 2003 - Fellow, American College of Chest Physicians 2008 - Member, Canadian Critical Care Trials Group

Teaching Experience, Nonmedical 1979 - 1982 Teaching Assistant in The History of Science, Harvard University

Professional Activities National and International


• Thematic Poster Session Facilitator, Ethics, Outcomes and Mechanical Ventilation, 1997 American Lung Association/American Thoracic Society International Conference, San Francisco, CA, May 1997.

• Thematic Poster Session Facilitator, Clinical Trials, 1998 American Lung Association/American Thoracic Society International Conference, Chicago, IL, April 1998.

• Invited Lecture, Symposium, Section of Pulmonary & Critical Care Medicine, Columbia University College of Physicians & Surgeons, New York City, NY, “Useless and Dangerous Practices in the Intensive Care Unit”, 9/28/1998.

• Invited Lecture, Symposium, Division of Pulmonary & Critical Care Medicine, University of Wisconson Medical School, Madison, WI, “The Relationship Between ICU Structure and ICU Performance”, 10/5/2000.

• Invited Lecture, Cardiology Grand Rounds, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, “Useless and Dangerous Practices in the Intensive Care Unit”, 10/10/2000.

• Invited Lecture, Pulmonary & Critical Care Grand Rounds, Case Western Reserve University, Cleveland, OH, “The Relationship Between ICU Structure and ICU Performance”, 12/8/2000.

• Invited Lecture, Symposium, Division of Pulmonary & Critical Care Medicine, Emory University, Atlanta, GA, “The Relationship Between ICU Structure and ICU Performance”, 12/12/2000.

• Invited Lecture, Critical Care Grand Rounds, University of Alberta, Edmonton, Alberta, Canada, “End-of-life Decision Making in the Intensive Care Unit”, 2/3/2003.

• Invited Lecture, Respirology Division Rounds, Dalhousie University, Halifax, Nova Scotia, Canada, “Advanced Cardiovascular Physiology”, 3/26/2003.

• Invited Lecture, Critical Care Grand Rounds, University of Calgary, Calgary, Alberta, Canada, “Improving ICU Outcomes by Improving ICU Structure”, 6/13/2003.

• Invited Lecture, Critical Care Medicine Research Conference, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, “Decision Analysis”, 11/18/2003.

• Invited Lecture, Critical Care Grand Rounds, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, “The Relationship Between Structure and Outcomes: Organizational Systems Engineering in the ICU”, 11/19/2003.

• Invited Lecture, Department of Medicine Grand Rounds, Bridgeport Hospital, Bridgeport, Connecticut, “Bayes Theorem at the Bedside”, 2/24/2005.

• Invited Lecture, Pulmonary & Critical Care Grand Rounds, Loyola University School of Medicine, Chicago, Illinois, “End-of-life Decision Making in the Intensive Care Unit”, 10/10/2005.

• Invited Lecture, Chicago Thoracic Society, Chicago, Illinois, “Radical Change is Needed to Optimize ICU Performance”, 10/11/2005.

• Invited Lecture, Pulmonary & Critical Care Grand Rounds, Northwestern University School of Medicine, Chicago, Illinois, “Quantitative Decision Analysis”, 10/12/2005.

• Invited Lecture, New Jersey Thoracic Society/New Jersey Chapter American College of Chest Physicians Thirty-Fourth Annual Joint Conference, New Brunswick, NJ, “Radical Change is Needed to Optimize ICU Performance”, 3/3/2006.

• Invited Lecture, 26th Myron B. Laver Critical Care International Postgraduate Course, Basel,Switzerland, “Radical Change is Needed to Optimize ICU Performance”, 3/18/2006.

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Performance Improvement in the ICU”, 11/12/2008

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Variation in ICU Care”, 11/13/2008

• Invited Lecture, World Federation of Societies of Intensive and Critical Care Medicine, Florence, Italy “Improving the ICU”, 8/30/2009


• Invited Lecture, World Federation of Societies of Intensive and Critical Care Medicine, Florence, Italy “Radical Change is Needed to Optimize ICU Performance”, 8/31/2009

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Why Good Studies Turn Out Wrong”, 10/26/2009

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Resident Scheduling Study: Editorial Comment”, 10/26/2009

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Is a 24 Hour Intensivist Necessary”, 10/26/2009

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Arterial Lines: Good or Bad?”, 10/27/2009

• Postgraduate Course, Co-Chair, The Science of Healthcare Delivery in the Intensive Care Unit, 2010 American Thoracic Society International Conference, New Orleans LA, 5/15/2010.

• Invited Lecture, American Thoracic Society 2010 International Conference, New Orleans, LA, “An Integrated View Of The Agenda For Improving ICU Care”, 5/15/2010

• Thematic Poster Session, Facilitator, ICU Management and Outcomes: Prediction, Procedures and Pot Pourri, 2010 American Thoracic Society International Conference, New Orleans, LA, 5/16/2010

• Poster Discussion Session, Co-Chair, Critical Care Management and Outcomes, American Thoracic Society International Conference, New Orleans, LA, 5/16/2010

• Invited Lecture, Department of Medicine Grand Rounds, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, “The Impact of Physician Scheduling in ICUs”, 12/2/2010.

• Invited Lecture, Center for Health Research and Policy, Case Western Reserve University, Cleveland, OH, “A New Method to Assess for Disparities in Access to Critical Care”, 12/3/2010.

• Invited Lecture, Division of Pulmonary & Critical Care Medicine, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, “Timing of Fluid Resuscitation in Septic Shock”, 12/3/2010.

• Mini-Symposium, Co-chair, Intensive Care Unit Staffing, American Thoracic Society International Conference, Denver, CO, 5/15/2011

• Invited Lecture, “Rethinking Monitoring Devices”, American Thoracic Society International Conference, Denver, CO, 5/16/2011

• Thematic Poster Session, Facilitator, ICU Management and Outcomes, 2011 American Thoracic Society International Conference, Denver, CO, 5/17/2011

• Invited Lecture, Patricia and Morton David Pulmonary Lecture, Beth Israel Hospital, New York City, NY, “Radical Change is Needed to Fix What’s Wrong With Medical Care”, 11/23/2011.

• Invited Lecture, Pulmonary & Critical Care Division Conference, Robert Wood Johnson Medical School, New Brunswick, NJ, “Long-term versus Short-term Prognositication in Critical Illness”, 10/15/2012.

• Invited Lecture, Department of Medicine Grand Rounds, Robert Wood Johnson Medical School, New Brunswick, NJ, “Outcomes Related to Leaving the Hospital Against Medical Advice: A Population-Based Analysis”, 10/16/2012.

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Reassessing Disparities in ICU Access”, 10/29/2012

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Administrative Database Research - What It Can and Cannot Do”, 10/30/2012

• Judge, Scientific Poster Competition, Critical Care Canada Forum, Toronto, Canada, 10/30/2012


• Invited Lecture, American Thoracic Society 2013 International Conference, Philadelphia, PA, “How do we know if ICU monitoring is useful? Clinical endpoints are the most relevant outcomes”, 5/17/2013

• Invited Lecture, Technology Evaluation in the Elderly, Annual Scientific Meeting, Toronto, Canada, “Sex Differences in Admission to Intensive Care Units: The Role of Social Support Factors”, 9/26/2013

• Symposium, Co-chair, Fluid Complications, Critical Care Canada Forum, Toronto, Canada, 11/10/2013

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Interaction of Fluids and Pressors in Septic Shock”, 11/10/2013

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Short vs. Long-term Mortality: Different Determinants?”, 11/12/2013

• Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Big Data Can Save Us”, 10/29/2014

• Judge, Scientific Poster Competition, Critical Care Canada Forum, Toronto, Canada, 10/30/2014 • Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Optimal Discharge from ICU”,

10/30/2014 • Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Using ICU Census Data to

Determine Bed Needs”, 10/31/2014. A video of this lecture is available at: https://www.youtube.com/watch?v=3b7zNtsZHpQ • Symposium, Co-chair, Following the Evidence: De-adopting Interventions in the ICU” 2015

American Thoracic Society International Conference, Denver, CO, 5/18/2015 • Poster Discussion Session, Chair, ICU Quality and Safety: Improvement Opportunities, American

Thoracic Society International Conference, Denver, CO, 5/20/2015 • Invited Lecture, Woods Hole Critical Care Research Retreat, Woods Hole, Massachusetts “The

Manitoba Data Repository”, 9/11/2015 • Invited Lecture, Woods Hole Critical Care Research Retreat, Woods Hole, Massachusetts “Post-

hospital Outcomes and Resource Use After ICU Care”, 9/11/2015 • Invited Lecture, 2016 American Thoracic Society International Conference, San Francisco,

California, “Poking Holes in Practice? Can Intensive Care be Less Invasive”, 5/16/2016 • Symposium, Co-chair, “Finding the Sweet Spot Between Too Much and Too Little Care” 2016

American Thoracic Society International Conference, San Francisco, 5/17/2016 • Invited Lecture, Critical Care Canada Forum, Toronto, Canada “Variation in ICU Care: Physician

Practice Patterns”, 11/1/2016. • Invited Lecture, Canadian Frailty Network 2017 Annual National Conference, Toronto, Canada

“Better tArgetting, Better outcomes for frail ELderly patients (The BABEL Study)”, 4/23/2017. • Invited Lecture, Section of Critical Care, MetroHealth Medical Center, Case Western Reserve

University, Cleveland, OH, “The Bidirectional Interface Between Critical Illness and Chronic Autoimmune Disease”, 2/7/2018.

• Invited Lecture, Department of Medicine Grand Rounds, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, “The Power of Big Data: Assessing an Important Patient-Oriented Outcome”, 2/8/2018.

• Presenter, Heart and Stroke Foundation of Canada Best Practices Webinar, “Return to Work After Stroke and Cardiac Events”, 4/10/2019. (1001 Registrants)

Local and Regional • Lecture, Medical Grand Rounds, Burdett Tomlin Hospital, Cape May, NJ, “Sedation in the

Intensive Care Unit”, 4/27/1994.


• Lecture, Medical Grand Rounds, Robert Wood Johnson Medical School, New Brunswick, NJ, “Oxygen Delivery and Oxygen Consumption in Critical Illness”, 12/14/1994.

• Lecture, Surgical Grand Rounds, CentraState Hospital, Freehold, NJ, “The Adult Respiratory Distress Syndrome”, 1/13/1995.

• Lecture, Staff Training Seminar, Hoffman-LaRoche Laboratories, Nutley, NJ, “Intravenous Sedation”, 1/4/1996.

• Lecture, Medical Grand Rounds, Robert Wood Johnson Medical School, New Brunswick, NJ, “Refining and Redefining the Goals of Therapy”, 3/6/1996.

• Lecture, Medical Grand Rounds, Mountainside Hospital, Montclair, NJ, “Beyond DNR: Defining the Goals of Therapy”, 9/12/1996.

• Lecture, New Jersey Thoracic Society/New Jersey Chapter American College of Chest Physicians Twenty-Fifth Annual Joint Conference, New Brunswick, NJ, “Useless and Dangerous Practices in the Intensive Care Unit”, 3/7/1997.

• Lecture, Medical Grand Rounds, Northwest Covenant Medical Center, Denville, NJ, “Beyond DNR: Defining the Goals of Therapy”, 4/1/1997.

• Lecture, Susquehanna Health System 11th Annual Critical Care Symposium, Williamsport, PA, “Useless and Dangerous Practices in the Intensive Care Unit”, 5/2/1997

• Lecture, Susquehanna Health System 11th Annual Critical Care Symposium, Williamsport, PA, “Beyond DNR: Defining the Goals of Therapy”, 5/2/1997

• Lecture, Medical Grand Rounds, Robert Wood Johnson Medical School, New Brunswick, NJ., “Useless and Dangerous Therapies in the Intensive Care Unit”, 6/11/1997.

• Lecture, Medical Grand Rounds, Princeton Medical Center, Princeton, NJ, “Beyond DNR: Defining the Goals of Therapy”, 6/17/1997.

• Lecture, Medical Grand Rounds, Harrisburg Hospital, Harrisburg PA, “Beyond DNR: Defining the Goals of Therapy”, 2/17/1998.

• Lecture, Symposium, Section of Pulmonary & Critical Care Medicine, Columbia University College of Physicians & Surgeons, New York City, NY, “Useless and Dangerous Practices in the Intensive Care Unit”, 9/28/1998.

• Lecture, Staff Training Seminar, Ortho-Biotech, Hamilton, NJ, “Introduction to the ICU Environment”, 8/9/1999.

• Lecture, Staff Training Seminar, Ortho-Biotech, Hamilton, NJ, “Important Disease States Treated in the ICU”, 8/9/1999.

• Lecture, Staff Training Seminar, Abbott Laboratories, Abbott Park, IL, “Infectious Disease in the Intensive Care Unit”, 10/2/1999.

• Lecture, Medical Grand Rounds, Lehigh Valley Hospital, Allentown, PA, “Quality in Medical Care: The Relationship Between Structure and Outcomes. The ICU as Example.”, 3/30/2000.

• Lecture, Symposium, Respiratory Care 2000, Robert Wood Johnson University Hospital, New Brunswick, N.J., “Liberation from Mechanical Ventilation: A Physiologic Approach”, 9/14/2000.

• Lecture, Medical Grand Rounds, Robert Wood Johnson Medical School, New Brunswick, NJ, “Update in Critical Care Medicine”, 9/27/2000.

• Lecture, Respiratory Care 2000 Symposium, Robert Wood Johnson University Hospital, New Brunswick, NJ, “Liberation from Mechanical Ventilation”, 9/14/2000.

• Lecture, Medical Grand Rounds, St. Peter’s University Hospital, New Brunswick, NJ, “Update in Critical Care Medicine”, 2/13/2001.

• Lecture, Department of Medicine Grand Rounds, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, “Useless and Dangerous Practices in the Intensive Care Unit”, 10/18/2001.


• Lecture, Cleveland Citywide Chest Conference, “The Physics of Heliox and its use in Asthma”, 9/4/2002.

• Lecture, Department of Medicine Grand Rounds, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, “End-of-Life Decision-Making”, 3/18/2004.

• Lecture, Pulmonary & Critical Care Grand Rounds, University Hospitals of Cleveland, Cleveland, Ohio, “Radical Change is Needed to Optimize ICU Performance”, 10/21/2005

• Lecture, Department of Medicine Grand Rounds, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, “Radical Change is Needed to Optimize Hospital Performance”, 1/5/2005.

• Lecture, Department of Medicine Grand Rounds, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, “A Few Really Important Things About Evidence-based Medicine”, 1/18/2007.

• Lecture, Pulmonary, Critical Care and Sleep Research Conference, University Hospitals of Cleveland, Cleveland, "Life Outside the Lab: Another Kind of ICU Research", 2/20/2007

• Lecture, Department of Medicine Grand Rounds, University of Manitoba Health Sciences Center, Winnipeg, MB, “A Few Really Important Things About Evidence-based Medicine”, 1/8/2008.

• Lecture, Manitoba Centre for Health Policy Research Forum, Winnipeg, MB, “Statistical Methods for Exploring the Relationship Between Continuous Variables”, 4/10/2008.

• Lecture, Department of Community Health Sciences Colloquium, University of Manitoba, Winnipeg, MB, “Radical Change is Needed to Improve Health Care”, 5/9/2008.

• Lecture, Department of Medicine Grand Rounds, University of Manitoba, Winnipeg, MB, “Radical Change is Needed to Improve Health Care”, 9/9/2008.

• Lecture, Department of Pediatrics Grand Rounds, University of Manitoba Health Sciences Center, Winnipeg, MB, “A Few Really Important Things About Evidence-based Medicine”, 9/11/2008.

• Lecture, Canadian Diabetes Association, Diabetes Educator Section, Winnipeg Chapter, “A Few Really Important Things About Evidence-based Medicine”, 11/25/2008.

• Lecture, Winnipeg Regional Health Authority, “Seminar in System Safety - Will standardization solve important problems?”, 4/16/2009.

• Lecture, Manitoba Centre for Health Policy, 20th Anniversary Conference, “Using MCHP Data for Research: One Clinician’s Experience”, 3/8/2010.

• Lecture, Manitoba Association of Asian Physicians Symposium, “The Nature of Evidence in Medical Pratice”, 9/8/2012.

• Lecture, Department of Anaesthesia Grand Rounds, University of Manitoba Health Sciences Center, Winnipeg, MB, “The Nature of Evidence in the Medical Literature”, 10/24/2012.

• Lecture, University of Manitoba Department of Community Health Sciences Research Lecture, “Changes in Work and Earnings after Heart Attack and Stroke: Research Plan”, 2/20/2015

• Research in Progress Lecture, University of Manitoba Section of Critical Care Medicine, “Changes in Work and Earnings after Heart Attack and Stroke”, 3/5/2015

• Research in Progress Lecture, University of Manitoba Section of Respirology, “Changes in Work and Earnings after Heart Attack and Stroke”, 3/12/2015

• Lecture, University of Manitoba Department of Psychiatry, Research Grand Rounds, “Mentorship in Research”, 7/28/2015

• Lecture, Winnipeg Regional Health Authority, Adult Critical Care Program, Annual Outcomes Improvement Symposium, “Issues in Safe Use of Analgesic and Sedative Drugs in ICU Patients”, 6/1/2017.

• Lecture, Department of Medicine Grand Rounds, University of Manitoba, Winnipeg, MB, “The Ability to Work and Earn: Assessment of an Important Patient-Centered Outcome”, 2/13/2018.


Bibliography: Summary Original research 77: First or senior author-42; Second author-12 Review articles 7 Government reports 2 Editorials 5 Correspondence 3 Conference presentations 80 Book chapters 13 Electronic media 2 Published software 1 Original Research Papers 1. A Garland, DW Ray, CM Doerschuk, M Jackson, S Eappen, L Alger, and J Solway. The role of

tachykinins in hyperpnea-induced bronchovascular hyperpermeability in guinea pigs. J. Appl. Physiol. 70(1):27-35, 1991. PMID:2010383

2. DW Ray, A Garland, C Hernandez, S Eappen, and J Solway. Time course of bronchoconstriction induced by dry gas hyperpnea in guinea pigs. J. Appl. Physiol. 70(2):504-510, 1991. PMID:2022539

3. MB Hershenson, S Aghili, N Punjabi, C Hernandez, DW Ray, A Garland, S Glagov, and J Solway. Hyperoxia-induced airway hyperresponsiveness and remodeling in immature rats. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L263-269, 1992. PMID:1550249

4. ME Strek, A Garland, C Abrahams, AR Leff, and SR White. Direct effects and augmentation of airway smooth muscle contraction caused by phospholipase A2. Am. Rev. Respir. Dis. 145(6):1463-1468, 1992. PMID:1596019

5. TR Hsuie, A Garland, DW Ray, MB Hershenson, AR Leff, and J Solway. Endogenous sensory neuropeptide release enhances non-specific airway responsiveness in guinea pigs. Am. Rev. Respir. Dis. 146(1):148-153, 1992. PMID:1320818

6. MB Hershenson, A Garland, MD Kelleher, A Zimmerman, C Hernandez, and J Solway. Hyperoxia-induced airway remodelling in immature rats: correlation with airway responsiveness. Am. Rev. Respir. Dis. 146(5):1294-1300, 1992. PMID:1443886

7. J Solway, R Kao, JE Jordon, B Gitter, IW Rodger, J Howbert, LE Alger, J Necheles, AR Leff, and A Garland. Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs. J. Clin. Investigation 92(1):315-323, 1993. PMID:8392088

8. TR Hsuie, AR Leff, A Garland, MB Hershenson, DW Ray, and J Solway. Impaired sensorineural function associated with allergic airway inflammation. Am. Rev. Respir. Dis. 148(2):447-454, 1993. PMID:7688201

9. A Garland, JE Jordon, DW Ray, S Spaethe, LE Alger, and J Solway. Role of eicosanoids in hyperpnea-induced airway responses in guinea pigs. J. Appl. Physiol. 75(6):2797-2804, 1993. PMID:8125904

10. MB Hershenson, MK Abe, MD Kelleher, ET Naureckas, A Garland, A Zimmerman, VJ Rubinstein, and J Solway. Recovery of airway structure and function after hyperoxic exposure in immature rats. Am. Rev. Respir. Dis. 149(6):1663-1669, 1994. PMID:8004327

11. A Garland, JE Jordon, DW Ray, LE Alger, C Hernandez, and J Solway. Hypertonicity, but not hypothermia, elicits Substance P release from C-fiber neurons in primary cell culture. J. Clin. Investigation 95(5): 2359-2366, 1995. PMID:7537764

12. SR White, A Garland, L Alger, J Necheles, KS Sigrist, and J Solway. Proliferation of guinea pig tracheal epithelial cells in co-culture with rat dorsal root ganglia neural cells. Am. J. Physiol.: Lung Cell. Mol. Biol. 268(6 Part 1):L957-L965, 1995. PMID:7611437


13. A Garland, J Necheles, SR White, SP Neeley, AR Leff, SS Carson, LE Alger, and J Solway. Activated eosinophils elicit Substance P release from cultured dorsal root ganglion neurons. Am. J. Physiol. 273(5 Pt 1):L1096-1102, 1997. PMID:9374740

14. HL Paz, A Garland, M Weinar, P Crilley, and I Brodsky. Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patients. Crit. Care Med. 26(1):66-70, 1998. PMID:9428545

15. TT Gilbert, MR Wagner, V Halukurike, HL Paz, and A Garland. Use of bispectral electroencephalogram monitoring to assess neurological status in unsedated, critically ill patients Crit. Care Med. 29(10):1996-2000, 2001. PMID:11588470

16. A Garland , NV Dawson, I Altmann, CL Thomas, RS Phillips, J Tsevat, NA Desbiens, PE Bellamy, WA Knaus, and AF Connors Jr. Outcomes up to five years after severe, acute respiratory failure. Chest. 126(6):1897-1904, 2004. PMID:15596690

17. A Garland, Shaman Z, Baron J and Connors AF, Jr. Physician-attributable Differences in Intensive Care Unit Costs: A Single-Center Study. Am. J. Respir. Crit. Care Med. 174(11):1206-1210, 2006. PMID:16973977

Subject of an accompanying editorial 18. A Garland and AF Connors Jr. Physicians’ Influence over Decisions to Limit Life Support. J.

Palliat. Med. 10(6):1298-1305, 2007. PMID:18095808 19. A Lenhard, M Moallem, R A Marrie, J Becker and A Garland. An Intervention to Improve

Procedure Education for Internal Medicine Residents. J. Gen. Int. Med. 23(3):288-293, 2008. PMID:18214624

20. YY Chen, AF Connors Jr. and A Garland. Effect of decisions to withhold life support on long-term survival. Chest. 133(6):1312-1318, 2008. PMID:18198259

Subject of an accompanying editorial 21. NA Ali, JM O’Brien, SP Hoffmann, G Phillips, A Garland, J Finley, K Almoosa, R Hejal, KM

Wolf, S Lemeshow, AF Connors, and C Marsh. Acquired weakness, handgrip strength and mortality in critically ill patients. Am. J. Respir. Crit. Care Med. 178(3):261-268, 2008. PMID:18511703

22. RA Marrie, NV Dawson and A Garland. Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables. J. Clin.Epidemiol. 62(5):511-517, 2009. PMID:19135859

23. BJ Daly, S Douglas, E O’Toole, NH Gordon, R Hejal, J Peerless, J Rowbottom, A Garland, C Lilly, C Wiencek, and R Hickman. Effectiveness Trial of an Intensive Communication Structure for Families of Long-stay ICU Patients. Chest. 138(6):1340-1348, 2010. PMID:20576734

24. NA Ali, KM Wolf , J Hammersley, S Hoffmann, JM O’Brien Jr, G Phillips, M Rashkin, E Warren and A Garland. Continuity of care in intensive care units: a cluster-randomized trial of intensivist staffing. Am. J. Respir. Crit. Care Med. 184(7):803-808, 2011. PMID:21719756

Subject of an accompanying editorial 25. A Garland, D Roberts and L Graff. 24 Hour Intensivist Presence: A Pilot Study of Effects on

ICU Patients, Families, Doctors and Nurses. Am. J. Respir. Crit. Care Med. 185(7):738-743, 2012. PMID:22246176

Subject of an accompanying editorial and podcast 26. A Garland, M Yogendran, K Olafson, DC Scales, K McGowan, and R Fransoo. The Accuracy

of Administrative Data for Identifying the Presence and Timing of Admission to Intensive Care Units. Medical Care. 50:e1-e6, 2012. PMID:22270100

27. R Fransoo, M Yogendran, K Olafson, C Ramsey, K McGowan, and A Garland. Constructing Episodes of Inpatient Care: Infrastructure for Population-based Critical Care Research. BMC Med. Res. Methodol. 12(1):133, 2012. PMID:22943606

http://www.ncbi.nlm.nih.gov/pubmed/21719756



28. D Horowitz, Y Amoateng, S Zarich, A Garland, and C Manthous. Arterial line or Cuff BP? Chest. 143(1):270-271, 2013. PMID:23276856

29. A Garland. Effect of Collaborative Care on Cost Variation in an Intensive Care Unit. Am. J. Crit. Care. 22(3):232-238, 2013. PMID:23635932

30. A Garland and AF Connors Jr. Optimal Timing of Transfer Out of the Intensive Care Unit. Am. J. Crit. Care. 22(5):390-397, 2013. PMID:23996418

Subject of a subsequent comment and response: Am. J. Crit. Care. 22(6):464, 2013. 31. T Sinuff, J Muscedere, NKJ Adhikari, HT Stelfox, P Dodek, D Heyland, G Rubenfeld, DJ Cook,

R Pinto, V Monaharan, J Currie, N Cahill, J Friedrich, A Amaral, D Piquette, DC Scales, S Dhanani, and A Garland, for the KRITICAL Working Group, the Canadian Critical Care Trials Group, and the Canadian Critical Care Society. Knowledge Translation Interventions for Critically Ill Patients: A Systematic Review. Crit. Care Med. 41(11):2627-2640, 2013. PMID:23939356

32. A Garland, CD Ramsey, R Fransoo, K Olafson, M Yogendran, and A Kraut. Rates of Readmission and Death Associated with Leaving Hospital Against Medical Advice: A Population-based Study. Can. Med. Assoc. J. 184(14):1207-1214, 2013. PMID:23979869

33. A Garland, K Olafson, C Ramsey, M Yogendran, and R Fransoo. Epidemiology of Critically Ill Patients in Intensive Care Units: A Population-based Observational Study. Crit. Care. 17(5):R212, 2013. PMID:24079640

34. A Kraut, R Fransoo, K Olafson, C Ramsey, M Yogendran, and A Garland. A Population-based Analysis of Leaving the Hospital Against Medical Advice: Incidence and Predictors. BMC:Health Services Research 13(1):415, 2013. PMID:24119500

35. J Spence, D Bell, and A Garland. Variation in Diagnostic Testing in Intensive Care Units: A Comparison of Teaching and Non-teaching Hospitals in a Regional System. Crit. Care Med. 42(1):9-16, 2014. PMID:24145835

Subject of an accompanying editorial. 36. HB Gershengorn, A Garland, A Kramer, DC Scales, G Rubenfeld, and H Wunsch. Variation of

Arterial and Central Venous Catheter Use in United States Intensive Care Units. Anesthesiology, 120(3):650-664, 2014. PMID:24424071

37. A Garland, K Olafson, C Ramsey, M Yogendren, and R Fransoo. Distinct Determinants of Short-term and Long-term Mortality After Critical Illness. Inten. Care Med. 40(8):1097-1105 2014. PMID:25011575

38. RA Marrie, CN Bernstein, CA Peschken, CA Hitchon, H Chen, R Fransoo, and A Garland. Intensive Care Unit Admission in Multiple Sclerosis: Increased Incidence and Increased Mortality. Neurology 82(23):2012-2019, 2014. PMID:24808019

39. RA Marrie, CN Bernstein, CA Peschken, CA Hitchon, H Chen, R Fransoo and A Garland. Increased Incidence of Critical Illness Among Patients with Inflammatory Bowel Disease: a Population-based Study. Clinical Gastroenterology and Hepatology, 12(12): 2063-2070, 2014. PMID:24726908

40. J Waechter, A Kumar, SE Lapinsky, J Marshall, P Dodek, Y Arabi, JE Parillo, RP Dellinger, and A Garland. Interaction Between Fluids and Vasoactive Agents on Mortality in Septic Shock: A Multicenter, Observational Study. Crit. Care Med. 42(10):2158-68, 2014. PMID:25072761

Subject of an accompanying editorial and podcast. 41. YY Chen, NH Gordon, AF Connors, A Garland, HS Lai, SJ Youngner. Factors associated with

two different protocols of do-not-resuscitate orders in a medical intensive care unit. Crit. Care Med. 42(10):2188-2196, 2014. PMID:24810524

42. HB Gershengorn, H Wunsch, DC Scales, R Zarychanski, G Rubenfeld, and A Garland. Association between Arterial Catheter Use and Hospital Mortality in Intensive Care Units. JAMA Int. Med. 174(11):1746-1754, 2014. PMID:25201069

Subject of an accompanying editorial.


43. YY Chen, NH Gordon, AF Connors, A Garland, SC Chang, and SJ Youngner. Two distinct do not-resuscitate protocols leaving less to the imagination: an observational study using propensity score matching. BMC Medicine, 12(1):146, 2014. PMID:25175307

44. A Garland, K Olafson, CD Ramsey, M Yogendran, R Fransoo. A Population-based Observational Study of ICU-Related Outcomes: With Emphasis on Post-Hospital Outcomes. Ann. Am. Thorac. Soc. 12(2):202-208, 2014. PMID:25521585

Subject of an accompanying editorial and podcast. 45. K Olafson, C Ramsey, M Yogendren, R Fransoo, E Forget, C Crusch and A Garland. Surge

Capacity: Analysis of Census Fluctuations to Estimate the Number of Intensive Care Unit Beds Needed. Health Serv. Res. 50(1):237-252, 2015. PMID:25040848

46. D Heyland, P Dodek, S Mehta, D Cook, A Garland, H Stelfox, SM Bagshaw, DJ Kutsogiannis, K Burns, J Muscedere, AF. Turgeon, R Fowler ,X Jiang, AG Day, for the Canadian Critical Care Trials Group and the Canadian Researchers at the End of Life Network. Admission of the very elderly to the intensive care unit: Family members' perspectives on clinical decision-making from a multicenter cohort study. Pall. Med. 29(4):324-335, 2015. PMID:25645668

47. CN Bernstein, A Garland, CA Peschken, CA Hitchon, H Chen, R Fransoo, RA Marrie. Predictors of ICU admission and outcomes one year post admission in persons with IBD: A population based study. Inflamm. Bowel Dis. 21(6):1341-1347, 2015. PMID:25989339

48. D Heyland, D Cook, SM Bagshaw, A Garland, H Stelfox, S Mehta, P Dodek, DJ Kutsogiannis, K Burns, J Muscedere, AF. Turgeon, R Fowler ,X Jiang, AG Day, for the Canadian Critical Care Trials Group and the Canadian Researchers at the End of Life Network. The Very Elderly Admitted to Intensive Care Unit: A quality finish? Crit. Care Med. 43(7):1352-1360, 2015. PMID:25901550.

49. RA Marrie, CN Bernstein, CA Peschken, CA Hitchon, H Chen, R Fransoo and A Garland. Health Care Utilization Before and After Intensive Care Unit Admission In Multiple Sclerosis. Mult. Sclerosis and Rel. Disorders. 4(4):296-303, 2015. PMID:26195046.

50. DK Heyland, A Garland, SM Bagshaw, D Cook, K Rockwood, HT Stelfox, P Dodek, RA Fowler, AF Turgeon, K Burns, J Muscedere, J Kutsogiannis, M Albert, Sa Mehta, X Jiang, AG Day, on behalf of the Canadian Critical Care Trials Group and the Canadian Researchers at the End of Life Network (CARENET). Recovery after critical illness in patients aged 80 years or older: a multi-center prospective observational cohort study. Inten. Care Med. 41(11):1911-1920, 2015. PMID:26306719

51. H Gershengorn, A Garland and M Gong. Patterns of Daily Costs Differ For Medical and Surgical Intensive Care Unit Patients. Ann. Am. Thorac. Soc. 12(12)1831-1836, 2015. PMID:26393984

52. YY Chen, N Gordon, AF Connors, A Garland, TS Chu, and S Youngner. The outcome of patients with two different protocols of do-not-resuscitate orders: an observational cohort study. Medicine 94(42):e1789, 2015. PMID:26496311

53. CA Peschken, CA Hitchon, A Garland, CN Bernstein, H Chen, R Fransoo, and RA Marrie. A Population-based Study of Intensive Care Unit Admissions in Rheumatoid Arthritis J. Rheumatology 43(1):26-33, 2016. PMID:26628597

54. DK Heyland, HT Stelfox, A Garland, D Cook, P Dodek, J Kutsogiannis, X Jiang, AG Day, the Canadian Critical Care Trials Group and the Canadian Researchers at the End of Life Network. Predicting Performance Status One Year after Critical Illness in Patients Aged 80 Years or Older: Development of a multivariable clinical prediction model. Crit. Care Med. 44(9):1718-1726, 2016. PMID:27075141

55. HB Gershengorn, DA Harrison, A Garland, ME Wilcox, KM Rowan, and H Wunsch. The Association between Intensive Care Unit Patient-to-Intensivist Ratios and Hospital Mortality. JAMA Int. Med. 177(3):388-396, 2017. PMID:28118657






56. A Garland, LM Metz, CN Bernstein, CA Peschken, CA Hitchon, and RA Marrie. Hospitalization is associated with subsequent disability in multiple sclerosis. Multiple Sclerosis and Related Disorders 14:23-28, 2017. PMID:28619426

57. R Marrie, C Hitchon, C Peschken, H Chen, C Bernstein, and A Garland. Health Care Utilization Before and After Intensive Care Unit Admission in Rheumatoid Arthritis. Clin and Exp Rheumatology 35(6):975-982, 2017. PMID:28598781

58. R Marrie, CN Bernstein, CA Peschken, CA Hitchon, H Chen, and A Garland. Increased Incidence of Critical Illness in Psoriasis. J Cut Med Surg 21(5):395-400, 2017. PMID:28587481

59. RA Marrie, EAC Sellers, H Chen, R Fransoo, CN Bernstein, CA Hitchon, CA Peschken, and A Garland. Markedly Increased Incidence of Critical Illness in Adults with Type 1 Diabetes. Diabetic Medicine 34(10):1414-1420, 2017. PMID:28626956

60. SM Bagshaw, X Wang, DA Zygun, D Zuege, P Dodek, A Garland, MD; D Scales, L Berthiaume, P Faris, G Chen, D Opgenorth, and HT Stelfox. Association Between Strained Capacity and Mortality among Patients Admitted to Intensive Care: A Path-Analysis Modeling Strategy. J. Crit. Care 43:81-87, 2017. PMID:28854400

61. C Sanmartin, A Reicker, A Dasylva, M Rotermann, SH Jeon, R Fransoo, H Wunsch, D Scales, TJ Iwashyna, M Stepner and A Garland. Data Resource Profile: Canadian Hospitalization and Taxation Database (C-HAT). Int. J. Epidemiol. 47(3):687–687g, 2018. PMID:29590346

62. MB Doupe, J Poss, PG Norton, A Garland, N Dik, S Zinnick, and LM Lix. How Well Does the Minimum Data Set Measure Healthcare Use? A Validation Study. BMC Health Serv. Res. 18(1):279, 2018. PMID:29642929

63. AM Hall, HT Stelfox, X Wang, G Chen, DJ Zuege, P Dodek, A Garland, DC Scales, L Berthiaume, DA Zygun and SM Bagshaw. Association Between Afterhours Admission to the Intensive Care Unit, Strained Capacity, and Mortality: A Retrospective Cohort Study. Crit. Care. 22(1):97, 2018. PMID:29665826

64. SW English, M Chass, AF Turgeon, F Lauzier, D Griesdale, A Garland, D Fergusson, R Zarychanski, C. van Walraven, K Montroy, J Ziegler, R Dupont-Chouinard, R Carignan, A Dhaliwal, R Mallick, J Sinclair, A Boutin, G Pagliarello, A Tinmouth, L McIntyre, on behalf of the Canadian Critical Care Trials Group. Anemia Prevalance and Incidence and Red Blood Cell Transfusion Practices in Aneurysmal Subarachnoid Hemorrhage: The Results of a Multi-center Cohort Study. Crit. Care 22(1):169, 2018. PMID: 29973245

65. A Garland, K Olafson, C Ramsey, M Yogendran, and R Fransoo. Reassessing Access to Intensive Care Using An Estimate of the Population Incidence of Critical Illness. Crit. Care 22(1):208, 2018. PMID:30122152

66. SW English, L McIntyre, V Saigle, M Chassé, D Fergusson, A Turgeon-Fournier, Fs Lauzier, D Griesdale, A Garland, R Zarychanski, A Algird; C van Walraven. The Ottawa SAH Search Algorithm: Protocol for A Multi-Centre Study to Validate a Novel and Innovative Primary SubArachnoid Hemorrhage Prediction Model using Health Administrative Data (The SAHepi Prediction Study Protocol). BMC Med. Res. Method. 18(1):94, 2018. PMID:30219029

67. TS Valley, DB Zahuranec, AJ Admon, A Garland, A Fagerlin, and TJ Iwashyna. Estimates of ICU benefit are influenced by factors unrelated to patient benefit: a randomized study of physicians. Crit. Care Med. 47(1):62-68, 2018. PMID: 30303839

68. A Garland, S Jeon, M Stepner, M Rotermann, R Fransoo, H Wunsch, DC Scales, TJ Iwashyna, and C Sanmartin. Effects of Cardiovascular and Cerebrovascular Health Events on Work and Earnings: A Population-Based, Retrospective Cohort Study. CMAJ 191(1):E3-E10, 2019. PMID: 30617227

Subject of an accompanying editorial


69. RA Marrie, A Garland, SA Schaffer, R Fransoo, S Leung, M Yogendran, E Kingwell, and H Tremlett. Traditional risk factors may not explain increased incidence of acute myocardial infarction in MS. Neurology. 92(14) e1624-e1633, 2019. PMID: 30842298

70. RA Marrie, H Tremlett, E Kingwell, A Schaffer, M Yogendran, F Zhu, R Fransoo, and A Garland. Disparities in management and outcomes of myocardial infarction in multiple sclerosis. Multiple Sclerosis Journal (epub ahead of print). PMID: 31517571

71. A Garland, RA Marrie, H Wunsch, M Yogendran, and D Chateau. Accuracy of Administrative Hospital Data to Identify Use of Life Support Modalities: A Canadian Study. Accepted for publication in Annals of the American Thoracic Society.

72. A Hill, J Kozak, C Ramsey, P Dodek, R Fransoo, R Fowler, H Wong, M Doupe, DC Scales, and A Garland. Examining mechanims for gender differences in admission to Intensive Care Units: A National Study. Health Serv. Res. (epub ahead of print), 2019. PMID: 31709536

73. SH Jeon, M Stepner, M Rotermann R Fransoo, C Sanmartin, DC Scales, H Wunsch, T. Iwashyna, and A Garland. Effects of Cardiovascular Health Shocks on Spouses’ Work and Earnings: A National Study. Accepted for publication in Medical Care.

74. BL Houston, K Uminski, T Mutter, E Rimmer, DS Houston, CE Menard, A Garland, R Ariano, AA Tinmouth, A Abou-Setta, R Rabbani, C Neilson, B Rochwerg, AF Turgeon, J Falk, R Breau, D Fergusson, R Zarychanski,. Efficacy and safety of tranexamic acid in major non-cardiac surgeries at high risk of transfusion: a systematic review and meta-analysis. Accepted for publication by Transfus. Med. Rev.

75. HB Gershengorn, DV Pilcher, E Litton, M Anstey, A Garland, H Wunsch. Association between consecutive days worked by intensivists and outcomes for critically ill patients. Accepted for publication by Crit. Care Med.

76. NJ Chornenki; P Liaw; S Bagshaw; K Burns; P Dodek; S English; E Fan; N Ferrari; A Fox-Robichaud; A Garland; R Green; P Hebert; M Kho; C Martin; D Maslove; E McDonald; K Menon; S Murthy; J Muscedere; D Scales; HT Stelfox; HT Wang; M Weiss; R Fowler. Data Initiatives Supporting Critical Care Research and Quality Improvement in Canada: an Environmental Scan. Accepted for publication by Can. J. Anaesth.

77. DK Heyland, F Marquis, F Lamontagne, M Albert, A Turgeon, K Khwaja, A Garland, R Hall, M Chapman, J Kutsiogannis, G Jones, C Martin, D Sessler, A Day. Esophageal motility to prevent regurgitation and enhance nutrition intake in Long-stay ICU patients (PROPEL): A multicenter, phase II, sham-controlled, randomized trial. Accepted for publication by Crit. Care Med.

Original Papers Under Review 1. S English, V Saigle, L McIntyre, M Chasse, D Ferguson, A Turgeon, F Lauzier, D Griesdale, A

Garland, R Zarychanski, A Algird, C van Walraven. Multi-Centre Validation of the Ottawa SAH Prediction Models using Health Administration Data. (under review at Lancet Neurology).

2. E. Rimmer, A Garland, A Kumar, S Doucette, B Houston, C Menard, M Leeies, AF Turgeon, S Mahmud, DS Houston and R Zarychanski. White Blood Count Trajectory and Mortality in Septic Shock: A Retrospective Cohort Study. (under review at Crit. Care Med.)

3. GA Heckman, V Boscart, P Quail, H Keller, C Ramsey, V Vucea, S King, I Bains, N Choi and A Garland. Mind the Gap: Shared challenges towards person-centered advance care planning in long-term care homes. The BABEL long-term care project. (under review at Can. J. Aging)


Papers in Preparation 1. B Haas. SH Jeon, M Rotermann, M Stepner, R Fransoo, C Sanmartin, H Wunsch, DC Scales,

TJ Iwashyna, and A Garland. Effect of Severe Trauma on Work and Earnings: A National Study. (in preparation for JAMA Surgery)

Government Reports 1. A Garland, R Fransoo, K Olafson, C Ramsey, M Yogendren, D Chateu and K McGowan. The

Epidemiology and Outcomes of Critical Illness in Manitoba. Manitoba Centre for Health Policy, 2012. Accessed April 18, 2012. Available at: http://mchp-appserv.cpe.umanitoba.ca/deliverablesList.html.

2. Care in Canadian ICUs. Canadian Institute for Health Information. Role: member of expert advisory panel. Accessed August 14, 2016. Available at: https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC3248&lang=en.

Review Articles 1. A Garland, and HL Paz. Outcome of marrow transplantation recipients requiring intensive care.

Sem. Resp. Crit. Care Med. 17(5):359-363, 1996. 2. A Garland. Improving the ICU: Part 1. Chest. 127(6):2151-2164, 2005. PMID:15947333 3. A Garland. Improving the ICU: Part 2. Chest 127(6):2165-2179, 2005. PMID:15947334 4. J Parry-Jones and A Garland. Resident full-time specialists in the ICU: a survivable model?

Curr. Opinion Crit. Care. 18(6):677-682, 2012. PMID:22941211 5. A Garland and H Gershengorn. Staffing in ICUs: Physicians and Alternative Staffing Models .

Chest. 143(1):214-221, 2013. PMID:23276844 6. A Garland, HB Gershengorn, RA Marrie, N Reider, and ME Wilcox. A Practical, Global

Perspective on Using Administrative Data to Conduct ICU Research. Ann. Am. Thorac. Soc. 12(9): 1373-1386, 2015. PMID:26148250

7. HB Gershengorn and A Garland. Who Should Be At the Bedside 24/7: Doctors, Families, Nurses? Sem. Resp. Crit. Care Med. 37(1):107-118, 2016. PMID:26820278

Invited Editorials 1. A Garland. Figuring out what works: A need for more and better studies on the relationship

between ICU organization and outcomes. Crit Care 14:108, 2010. PMID:20156315 2. A Garland, and AF Connors. Indwelling Arterial Catheters in the ICU: Necessary and

Beneficial, or a Harmful Crutch? Am.J. Respir. Crit. Care Med. 182(2):133-134, 2010. PMID:20634498

3. A Katz, A Garland, W Leslie, and M Moffatt. Clinical Research at MCHP Over the Next 20 Years. Healthcare Policy 6(Special Issue):88-90, 2011. PMID:24933379

4. A. Garland. Arterial Lines in the ICU: A Call for Rigorous Controlled Trials. Chest. 146(5):1155-1158, 2014. PMID:25367469

5. A. Garland. Labor Market Outcomes: Expanding the List of Patient-Centered Outcomes in Critical Care. Am J Resp Crit Care Med. 196(8):946-947, 2017. PMID:28510473

Correspondence 1. A Garland. Response. [Response to Letter] Am J Crit Care 22(6):464, 2013. PMID:24186813 2. WD Freeman, RA Marrie, and A Garland. Response. [Response to Letter] Neurology

83(2):2192-2193, 2014. PMID:25452459. 3. AC Jackson, and A Garland. Fatal Rabies Case Did Not Die "Accidentally" and Should Not Be

Considered a Rabies Survivor. Ped Infec Dis J. 34(6):677-678, 2015. PMID:25970114

http://www.longwoods.com.proxy1.lib.umanitoba.ca/content/22125

http://www.longwoods.com.proxy1.lib.umanitoba.ca/content/22125


Conference presentations, Abstracts 1. T Lewis, E Choi, J Melendres, A Garland, LDH Wood, and KR Walley. Response of a canine

model of L-lactic acidemia to bicarbonate infusion. Am Rev. Resp. Dis. 137(4, Part 2):114, 1988.

2. M Hershenson, D Ray, A Garland, L Alger, C Hernandez, R Bullock, and J Solway. Hyperoxia increases airway reactivity in immature rats. Physiologist 33(4):A80, 1990.

3. A Garland, D Ray, TR Hsiue, L Alger, MB Hershenson, and J Solway. Role of eicosanoids in hyperpnea-induced bronchoconstriction (HIB) and bronchovascular hyperpermeability (HIBVH) in guinea pigs. Am. Rev. Respir. Dis. 143(4, Part 2): A539, 1991.

4. TR Hsiue, A Garland, D Ray, MB Hershenson, AR Leff, and J Solway. Allergen challenge enhances guinea pig bronchoconstrictor responses to acetylcholine (ACh) and substance P (SP) but not dry gas hyperpnea. Am. Rev. Respir. Dis. 143(4, Part 2): A540, 1991.

5. N Punjabi, M Hershenson, J Umans, J Tallet, R Mitchell, A Garland, and J Solway. Exposure of immature rats to hyperoxia increases tracheal smooth muscle force generation in vitro. Am. Rev. Respir. Dis. 143(4, Part 2): A553, 1991.

6. M Hershenson, S Aghili, N Punjabi, A Garland, D Ray, C Hernandez, A Zimmerman, S Glagov, and J Solway. Hyperoxia induces airway hyperresponsiveness and remodelling in immature rats. Am. Rev. Respir. Dis. 143(4, Part 2): A554, 1991.

7. A Garland, JE Jordan, C Lilly, JM Drazen, RJ Miller, C Hernandez, LE Alger, and J Solway. Both hyperosmolarity and cooling elicit NKA release from dorsal root ganglion cells in primary culture. FASEB J. 6(5, Part 2): A1807, 1992.

8. A Garland, JE Jordan, B Kao, J Gitter, J Howbert, J Necheles, and J Solway. Neurokinin-1 (NK-1) receptor blockade with (+/-) CP-96,345 inhibits hyperpnea-induced bronchoconstriction (HIB) in guinea pigs. Am. Rev. Respir. Dis. 145(4, Part 2): A45, 1992.

9. J Solway, A Garland, M Kelleher, A Zimmerman, C Hernandez, and M Hershenson. Hyperoxia-induced airway remodelling in immature rats: correlation with airway responsiveness. Am. Rev. Respir, Dis. 145(4, Part 2): A14, 1992.

10. A Garland, JE Jordon, S Neeley, SR White, J Necheles, LE Alger, AR Leff, and J Solway. Effects of eosinophil products upon sensory C-fiber neurons in cell culture. Am. Rev. Respir. Dis. 147(4, Part 2): A816, 1993.

11. J Solway, DW Ray, BD Gitter, IW Rodger, LE Alger, and A Garland. NK-2, but not NK-1, receptor blockade inhibits hyperpnea-induced bronchoconstriction (HIB) in guinea pigs. Am.J. Respir. Crit. Care Med. 149(4, Part 2):A892, 1994.

12. SR White, A Garland, L Alger, KS Sigrist, J Necheles, and J Solway. Proliferation of guinea pig tracheal epithelial cells in co-culture with rat dorsal root ganglia neural cells. Am.J. Respir. Crit. Care Med. 149(4, Part 2):A996, 1994.

13. B Wagner, J Denny, S Hatfield, A Garland, L D’Amelio and M Bueno. Perception of drug action and cost by acute care professionals. Crit. Care Med. 24(1):A63, 1996.

14. A Garland. TM Kilkenny, MA Anderson, A Simone, J Scharf and HL Paz. Care of ICU patients by intensivists vs. non-intensivists. Am.J. Respir. Crit. Care Med. 153(4, Part 2):A360, 1996.

15. C Robitaille, R Contrada, H Leventhal, E Leventhal, TM Kilkenny, MA Anderson, HL Paz and A Garland. An instrument to measure physician practice styles in the ICU. Am.J. Respir. Crit. Care Med. 155(4, Part 2):A766, 1997.

16. A Garland, TM Kilkenny, MA Anderson and HL Paz. Physician-attributable differences in care of ICU patients. Am.J. Respir. Crit. Care Med. 155(4, Part 2):A766, 1997.

17. A Garland, M Anderson, T Kilkenny, E Kim, A Rosa and HL Paz. Characteristics of length of stay outliers in a medical intensive care unit. Am.J. Respir. Crit. Care Med. 157(3, Part 2):A302, 1998.


18. E Kim, MA Anderson, M Wagner, HL Paz and A Garland. Effects of resuscitation status upon resource use in the ICU. Am.J. Respir. Crit. Care Med. 159(3, Part2):A82, 1999.

19. TT Gilbert, V Halukurike, M Wagner, HL Paz and A Garland. Bispectral index and other spectral EEG indices correlate with neurologic status in unsedated ICU patients. Am.J. Respir. Crit. Care Med. 159(3, Part2):A827, 1999.

20. A Garland, M Wagner and HL Paz. ICU resource use by university vs. community based intensivists. Am.J. Respir. Crit. Care Med. 161(3, Part2):A236, 2000.

21. A Garland, NV Dawson, CL Thomas and AF Connors Jr. Post-hospital survival up to five years after acute respiratory failure. Am.J. Respir. Crit. Care Med. 169(7):A18, 2004.

22. A Garland, NV Dawson, CL Thomas and AF Connors Jr. The consensus definition of ARDS has no prognostic value in acute respiratory failure. Am.J. Respir. Crit. Care Med. 169(7):A349, 2004.

23. J Baron, MJ Roach, RD Cebul, AF Connors Jr. and A Garland. The effect of work schedule on job stress among intensivists. Am.J. Respir. Crit. Care Med. 169(7):A40, 2004.

24. MK Anthony, A Abdrbo and A Garland. Work Group Identification: Perceptions of Nurses Working in Acute Care. (Presented at 2004 AcademyHealth Annual Research Meeting, San Diego, CA).

25. A Garland, and J Baron. Continuity of Care and Patient Outcomes in the ICU. Am.J. Respir. Crit. Care Med. Proc Am Thoracic Soc. 2:A595, 2005.

26. Z Shaman, J Conklin, and A Garland. Concordance of Glasgow Coma Scale Scoring by Nurses and Intensivists. Proc Am Thoracic Soc. 2:A428, 2005.

27. Z Shaman, MJ Roach, P Marik, S Carson, and A Garland. Job Stress and Workload Among Intensivists. Proc Am Thoracic Soc. 2:A597, 2005.

28. A Garland, Shaman Z, and AF Connors. Differences in ICU Costs between Individual Intensivists Proc Am Thoracic Soc. 3:A380, 2006.

29. AF Connors, and A Garland. Quantifying Physicians' Influence over End-of-Life Decision-Making. Am.J. Respir. Crit. Care Med. 175(Abstracts issue):A549, 2007.

30. YY Chen, AF Connors, and A Garland. Influence of Withholding Life Support to the Long-term Survival of ICU Patients After They Survive to Hospital Discharge. American Society for Bioethics and Humanities, 9th Annual Meeting, Washington, D.C., October 18-21, 2007.

31. A Garland, and AF Connors. ICU Costs in the Real World: Impact of Multiple Physicians. Am.J. Respir. Crit. Care Med. 177(Abstracts issue):A959, 2008.

32. A Garland, and AF Connors. Optimal Timing of Transfer out of ICU. Am.J. Respir. Crit. Care Med. 177(Abstracts issue):A126, 2008.

33. NA Ali, JM O’Brien, SP Hoffman, GS Phillips, A Garland, JCW Finley , K Almoosa, R Hejal, KM Wolf, AF Connors, and CB Marsh. Acquired Weakness, Handgrip Strength and Mortality in Critically Ill Patients. Am.J. Respir. Crit. Care Med. 177(Abstracts issue):A40, 2008.

34. NA Ali, M Green, JM O’Brien, SP Hoffman, GS Phillips, A Garland, JCW Finley, AF Connors, K Almoosa, R Hejal, KM Wolf, and CB Marsh. Clinical Factors Associated with Handgrip Strength in Critically Ill Patients. Am.J. Respir. Crit. Care Med. 177(Abstracts issue):A370, 2008.

35. J Waechter, A Garland, and A Kumar. Early Administration of Crystalloid Fluids Reduces Mortality in Septic Shock. Am.J. Respir. Crit. Care Med. 181:A4097, 2010.

36. A Garland, R Fransoo, K Olafson, K McGowan, M Yogendran, and D Scales. Specific Reporting Requirements Improves the Accuracy of Administrative Data for Identifying Intensive Care Unit Admission. Am.J. Respir. Crit. Care Med. 181:A1653, 2010.

37. K Olafson, C. Ramsey, M Yogendran, J Wachter, R Fransoo, and A Garland. Age related changes in intensive care bed utilization over time: A population based study. Am.J. Respir. Crit. Care Med. 181:A1650, 2010.


38. K Olafson, M Yogendran, C Ramsey, J Wachter, A Garland, and R Fransoo. Utilization of intensive care unit beds in a Canadian population. Am.J. Respir. Crit. Care Med. 181:A5345, 2010.

39. CD Ramsey, K Olafson, M Yogendran, J Waechter, A Garland, and R Fransoo. Gender Differences in Intensive Care Utilization. Am.J. Respir. Crit. Care Med. 181:A1651, 2010.

40. R Fransoo, M Yogendran, C Ramsey, K Olafson, J Waechter, and A Garland. Sex differences in intensive care unit use. Presentation at the Canadian Association for Health Services and Policy Research Conference, Toronto, ON, May 11, 2010.

41. A Garland. Effects on Patients, Physicians and Families of 24 Hour, On-Site Intensivist Coverage in Academic and Community ICU Care. Am.J. Respir. Crit. Care Med. 183:A1024, 2011.

42. A Garland, K Olafson, C Ramsey, M Yogendren, and R Fransoo. Reassessing Disparities in Access to Intensive Care Using a New Methodology. Am.J. Respir. Crit. Care Med. 183:A4110, 2011.

43. C Ramsey, K Olafson, M Yogendren, R Fransoo and A Garland. Resource Utilization After Survival From Critical Illness. Am.J. Respir. Crit. Care Med. 183:A4117, 2011.

44. K Olafson, C Ramsey, M Yogendren, R Fransoo, C Crusch and A Garland. Comparison of different methods to describe intensive care bed use. Am.J. Respir. Crit. Care Med. 183:A2381, 2011.

45. NA Ali, K Wolf, J Hammersley, S Hoffmann, J O'Brien, G Phillips, M Rashkin, T Warren and A Garland. Comparison of alternative intensivist staffing schedules on physician and patient outcomes in the intensive care unit. Am.J. Respir. Crit. Care Med. 183:A1026, 2011.

46. CA Peschken, CA Hitchon, H Chen, A Garland, HS El-Gabalawy, CN Bernstein, RA Marrie. Administrative Definitions of Rheumatoid Arthritis: Rising Prevalence Regardless of Definition Used. Arthritis and Rheumatism 63(10 suppl):S1009, 2011.

47. T Sinuff, J Muscedere, N Adhikari, T Stelfox, G Rubenfeld, PM Dodek, R Pinto, D Heyland, D Cook, A Amaral, D Piquette, N Cahill, B Lawless, DC Scales and A Garland. The Quality Of Knowledge Translation Studies In Critical Care. Am.J. Respir. Crit. Care Med. 185:A1483, 2012.

48. T Sinuff, A Garland, N Adhikar, T Stelfox, G Rubenfeld, PM Dodek, D Heyland, R Pinto, D Cook, A Amara, D Piquette, N Cahil, B Lawless, DC Scales, and J. Muscedere. Knowledge Translation Interventions For Critically Ill Patients: A Systematic Review. Am.J. Respir. Crit. Care Med. 185:A2460, 2012.

49. K Olafson, CD Ramsey, R Fransoo, M Yogendran and A Garland. Differences Between Intensive Care Unit Admissions Located In Rural And Urban Hospitals In A Canadian Population. Am.J. Respir. Crit. Care Med. 185:A1632, 2012.

50. K Olafson, CD Ramsey, R Fransoo, M Yogendran and A Garland. Comparing Use Of Intensive Care Units Between Rural And Urban Canadian Populations. Am.J. Respir. Crit. Care Med. 185:A1633, 2012.

51. A Garland, K Olafson, C Ramsey, M Yogendren, K McGowan, R Fransoo. Changes Over Time in Intensive Care Unit Admission Diagnoses: A Population-Based Analysis. Am.J. Respir. Crit. Care Med. 185:A2551, 2012.

52. CD Ramsey, K Olafson, M Yogendran, R Fransoo and A Garland. Sex Differences In Intensive Care Unit (ICU) Admission Characteristics And Outcomes. Am.J. Respir. Crit. Care Med. 185:A2550, 2012.

53. R Fransoo, K Olafson, M Yogendran, CD Ramsey, K McGowan, and A Garland. How many ICU beds does a population need? Presentation at the 2012 meeting of The Canadian Association for Health Services and Policy Research, Montreal, Quebec, Canada, May 29, 2012.

http://www.google.ca/url?sa=t&rct=j&q=cahspr&source=web&cd=1&ved=0CB0QFjAA&url=http%3A%2F%2Fwww.cahspr.ca%2F&ei=nY8MT_jlFYfnggeJs72sBw&usg=AFQjCNE-xuZWSChcMjp9Xg1AYzNtwOwVxg

http://www.google.ca/url?sa=t&rct=j&q=cahspr&source=web&cd=1&ved=0CB0QFjAA&url=http%3A%2F%2Fwww.cahspr.ca%2F&ei=nY8MT_jlFYfnggeJs72sBw&usg=AFQjCNE-xuZWSChcMjp9Xg1AYzNtwOwVxg


54. CA Peschken, CA Hitchon, A Garland, CN Bernstein, R Fransoo, and RA Marrie. Shared High Risk of Intensive Care Unit Admission in Three Autoimmune Inflammatory Diseases. Arthritis and Rheumatism 64:(10 Suppl):S408, 2012.

55. CA Peschken, CA Hitchon, A Garland, CN Bernstein, R Fransoo, and RA Marrie. High Risk of Intensive Care Unit Admission in Rheumatoid Arthritis Patients: A Population Based Study. Arthritis and Rheumatism 64:(10 Suppl):S1073, 2012.

56. CN Bernstein, A Garland, C Peschken, C Hitchon, R Fransoo, and RA Marrie. Increased risk of intensive care unit (ICU) admission in inflammatory bowel disease (IBD). Gastroenterology 144(5,Suppl1), S618, 2013.

57. RA Marrie, C Peschkin, CN Bernstein, C Hitchon, R Fransoo and A Garland. Increased Risk of Intensive Care Unit Admission in Multiple Sclerosis. Neurology. 80(Meeting Abstracts 1):P03.205, 2013. Available at: http://www.neurology.org/cgi/content/meeting_abstract/80/1_MeetingAbstracts/P03.205. Accessed June 7, 2013.

58. A Garland, K Olafson, C Ramsey, M Yogendren, R Fransoo. Distinct Determinants of Long-term and Short-term Survival in Critical Illness. Am.J. Respir. Crit. Care Med. 187:A5075, 2013.

59. A Garland, C Hitchon, C Bernstein, C Peschkin, R Fransoo and RA Marrie. The Interface Between Critical Illness and Chronic Inflammatory Disorders: Incidence and Mortality. Am.J. Respir. Crit. Care Med. 187:A5288, 2013.

60. J Spence, D Bell, and A Garland. Variation in Diagnostic Testing in Intensive Care Units: A Comparison of Teaching and Nonteaching Hospitals in a Regional System. Chest. 144(4_MeetingAbstracts):582A, 2013.

61. C Ramsey, R Fowler, PM Dodek, R Fransoo, M Doupe, H Wong, J Kozak, A Hill, H Chen, M Yogendran and A Garland. The Effects of Widowhood on Sex Differences in Admission to Intensive Care Units. Am.J. Respir. Crit. Care Med. 191:A1393, 2015.

62. SM Bagshaw, X Wang, DA Zygun, D Zuege, P Dodek, A Garland, D Scales, L Berthiaume, D Yergens, P Faris, G Chen, HT Stelfox. Capacity Strain Increases Mortality Risk among Patients Admitted to Intensive Care Units – A Two-Stage Modeling Strategy. Presented at Canadian Critical Care Forum, Toronto, Ontario, October, 2015.

63. SW English, M Chassé, AF Turgeon, F Lauzier, D Griesdale, A Garland, D Fergusson, R Zyrachanski, K Montroy, J Ziegler, R Dupont Chouinard, R Carignan, C vanWalraven, C Lum, J Sinclair, G Pagliarello, A Tinmouth, L McIntyre for the SAHaRA Investigators and the CCCTG. Anemia Remains a Common and Early Complication Following Aneurysmal Subarachnoid Hemorrhage: SAHaRA - a Canadian Multi-Centre Retrospective Cohort Study. Presented at Canadian Critical Care Forum, Toronto, Ontario, October, 2015.

64. C Sanmartin, A Reicker, A Garland, TJ Iwashyna, R Fransoo, D Scales, H Wunsch, E Forget and H Qiu. Linking Hospital and Tax data to support research on the economic impacts of hospitalization. Presented at International Population Data Linkage Network Conference, Swansea, UK, August 24, 2016. Intl. J. Pop. Data Science 1(1):246, 2017.

65. CD Ramsey, A Hill, P Dodek, R Fowler, J Kozak, H Wong, R Fransoo, M Doupe, M Yogendran, A Garland. Male Predominance in Admission to Intensive Care Units (ICU) Disappears After Surviving One ICU Admission. Presented at 2016 American Thoracic Society International Conference, San Francisco, May 16, 2016. Am.J. Respir. Crit. Care Med. 193:A2957, 2016.

66. A Hill, CD Ramsey, P Dodek, J Kozak, M Doupe, R Fowler, H Wong, R Fransoo, DC Scales, A Garland. Marital Status Does Not Explain the Male Predominance of ICU Admission Among Home Care Clients. Presented at 2016 American Thoracic Society International Conference, San Francisco, May 16, 2016. Am.J. Respir. Crit. Care Med. 193:A3642, 2016.

67. A. Garland, LM Metz, CN Bernstein, CA Peschken, CA Hitchon, and RA Marrie. Effect of Acute Illness on the Course of Chronic Disease: The Example of Multiple Sclerosis. Presented at the 2017 American Thoracic Society International Conference, Washington D.C., May 21, 2017. Am.J. Respir. Crit. Care Med. 195:A1783, 2017.




68. RA Marrie, LM Metz, and A Garland. The effect of hospitalization on subsequent disability in multiple sclerosis. Presented at the American Academy of Neurology 69th Annual Meeting, Boston, MA, April 27, 2017.

69. R Fransoo, C Sanmartin, TJ Iwashyna, D Scales, H Wunsch, SH Jeon, M Rotermann, M Stepner, A Garland. The impact of acute cardiovascular events on employment and income. Presented at 2017 Canadian Association for Health Services and Policy Research Conference, Toronto, ON, May 25, 2017.

70. SH Jeon, A Garland, C Sanmartin, D Scales, H Wunsch, TJ Iwashyna, M Rotermann, M Stepner, and R Fransoo. The impact of acute cardiovascular events on labor market outcomes. Presented at 2017 International Health Economics Association, Boston, MA, July 9, 2017.

71. R Fransoo, A Garland, SH Jeon, M Rotermann, M Stepner, C Sanmartin, G Schellenberg, H Wunsch, B Haas, D Scales, and TJ Iwashyna. In Sickness and In Health: Effects of Cardiovascular Health Shocks on Spouses’ Work and Earnings. Presented at the 2018 International Population Data Linkage Network, Banff, Alberta, September 13, 2018.

72. E Rimmer, DS Houston, B Houston, C Menard, M Leeies, S Mahmud, A Kumar, A Garland, and R Zarychanski. White Blood Cell Count Trajectory and Mortality in Septic Shock: A Retrospective Cohort Study. Presented at 2018 Canadian Student Health Research Forum, Winnipeg, Manitoba, June 13, 2018.

73. TS Valley, AJ Admon, DB Zahuranec, A Garland, A Fagerlin, and TJ Iwashyna. Estimates of ICU benefit are influenced by factors unrelated to severity of illness: A randomized study of physicians. Presented at the 2018 American Thoracic Society International Conference, San Diego, CA, May 21, 2018. Am.J. Respir. Crit. Care Med. 197:A6289, 2018.

74. RA Marrie, A Garland, A Schaffer, R Fransoo, S Leung, M Yogendran, E Kingwell, H. Tremlett. Multiple sclerosis is associated with an increased risk of acute myocardial infarction. Presented at the 2018 ECTRIMS Conference, Berlin, Germany, October 10, 2018.

75. Rimmer E, Doucette S, Houston DS, Houston BL, Menard CE, Leeies M, Mahmud S, Kumar A, Garland A, and Zarychanski R; for the Acute Care Hematology Research Cluster. White Blood Cell Count Trajectory and Mortality in Septic Shock: A Retrospective Cohort Study. Presented at the American Society of Hematology Annual Meeting. San Diego, December 2, 2018.

76. MO Rahman, A Khalifa, R Vaisler, E Charbonney, W Alhazzani, K Gossack-Keenan, A Garland, T Karachi, E Duan, S Bagshaw, M Meade, C Hillis, P Kavsak, K Born, L Mbuagbaw, D Siegal, T Miller, P Austin, D Scales, A Amaral, S English, V McCredie, P Dodek, DJ Cook, B Rochwerg. A Canada-wide survey of perceptions and practices related to routine blood test ordering in the ICU: a RUBIC research program study. Presented at the Choosing Wisely Canadian National Meeting. Montreal, May 27, 2019.

77. A Khalifa, P Dodek, C Hillis, A Garland, E Duan, E Belley-Cote, P Kavsak, T Karachi, D Siegal, W Alhazzani, T Millen, D Heels-Ansdell, O Rahman, K Born, S English, V McCredie, E Charbonney, L Mbuagbaw, D Scales, S Bagshaw, A Amaral, M Meade, D Cook, B Rochwerg. Reducing Unnecessary Bloodwork in the Critically Ill (RUBIC): A Multi-Center Prospective Audit. Presented at the 2019 American Thoracic Society International Conference, Dallas, TX, May 21, 2019.

78. A Garland, SH Jeon, M Rotermann M Stepner R Fransoo, C Sanmartin, H Wunsch, D C. Scales, TJ Iwashyna, and B Haas. Effect of Severe Trauma on Work and Earnings. Presented at the 2019 American Thoracic Society International Conference, Dallas, TX, May 19, 2019.

79. SW English, V Saigle, L McIntyre, M Chasse, DA Fergusson, AF Turgeon, F Lauzier, D Griesdale, A Garland, R Zarychaski, A Algird and C van Walraven. Multi-centre Validation Study of the Ottawa SAH Prediction Models. Presented at the 15th International Conference on Subarachnoid Hemorrhage. Amsterdam, Netherlands, June 26, 2019.

80. G Heckman, A Garland, I Bains, V Boscart, N Choi, M Heyer, H Keller, S King, T Oshchepkova, P Quail, C Ramsey, J Steer and V Vucea. Navigating the gaps: Shared challenges towards


person-centered advance care planning in long-term care homes. Results of a Canadian interprovincial workshop. Presented at the 48th Annual Scientific and Educational Meeting of the Canadian Association of Gerontology. Moncton, New Brunswick, Canada, October 26, 2019.


Book Chapters 1. A Garland. Oxygen delivery and pathological supply dependence of oxygen utilization. In:

Principles of Critical Care: A companion text, edited by JB Hall, GA Schmidt, and LDH Wood. New York: McGraw Hill 1993.

2. A Garland. Pericardial involvement in critical illness. In: Principles of Critical Care: A companion text, edited by JB Hall, GA Schmidt, and LDH Wood. New York: McGraw Hill 1993.

3. A Garland. Overview of respiratory failure. In: Principles of Critical Care: A companion text, edited by JB Hall, GA Schmidt, and LDH Wood. New York: McGraw Hill 1993.

4. A Garland. Acid-base disorders in the ICU. In: Principles of Critical Care: A companion text, edited by JB Hall, GA Schmidt, and LDH Wood. New York: McGraw Hill 1993.

5. A Garland. Lactic acidosis. In: Principles of Critical Care: A companion text, edited by JB Hall, GA Schmidt, and LDH Wood. New York: McGraw Hill 1993.

6. J Solway, DW Ray and A Garland. Sensory neuropeptides in an animal model of hyperpnea-induced bronchoconstriction. In: Neuropeptides in Respiratory Medicine, edited by M Kaliner, PJ Barnes, G Kunkel and J Baraniuk. New York: Marcel Dekker 1995.

7. A Garland, and J Solway. Novel antiinflammatory drugs in asthma. In: Pulmonary and Critical Care Pharmacology and Therapeutics, edited by AR Leff. New York: McGraw Hill 1996.

8. A Garland, and HL Paz. Improving the Intensive Care Unit. In: Principles of Critical Care 2nd edition, edited by JB Hall, GA Schmidt, and LDH Wood. New York: McGraw Hill 1998.

9. A Garland. Improving the Quality of Care in the Intensive Care Unit. In: Principles of Critical Care 3rd edition, edited by JB Hall, GA Schmidt, and LDH Wood. New York: McGraw Hill 2005.

10. A Garland. Improving the Intensive Care Unit. In: Surgical Intensive Care Medicine 2nd edition, edited by JM O’Donnell, and FE Nacul. New York: Springer 2009.

11. A Garland. Improving Quality of Care in ICUs. In: Intensive and Critical Care Medicine, edited by A Gullo, J Besso, PD Lumb, and GF Williams. Milan: Springer 2009.

12. H Gershengorn and A Garland. Intensivist and Alternative Models of ICU Staffing. In: The Organization of Critical Care: An Evidence-Based Approach to Improving Quality, edited by G Rubenfeld and D Scales. New York: Humana Press 2014.

13. A Garland, H Gershengorn, and CA Manthous. Intensive Care Unit Staffing. In: Principles of Critical Care 4th edition, edited by JB Hall, GA Schmidt, JP Kress. New York: McGraw Hill 2015.

Electronic Media 1. A Garland. Critical Care Chest Radiology. In: Essentials of Radiology (CD ROM), edited by

JK Amorosa. Medical Interactive (www.medinter.com) 1999. 2. Journal Watch General Medicine. Interview about original research paper #24, 11/27/2011.

Available at http://general-medicine.jwatch.org/cgi/content/full/2011/1027/7; accessed 11/2/2011.

Software 1. M Stepner and A Garland. -calipmatch- Stata module for caliper matching without replacement. Item S458342, available at: https://ideas.repec.org/s/boc/bocode.html; posted 2017

Trainee Research Supervision 1. Eric Kim, M.P.H., Rutgers University, 1997. “Economic consequences of Do Not Resuscitate

orders in the Intensive Care Unit.” Allan Garland, MD, MA, Fieldwork Supervisor for M.P.H. 2. Tricia Gilbert, MD, Robert Wood Johnson University Hospital, 2000-01. Internal Medicine

resident research project.

http://general-medicine.jwatch.org/cgi/content/full/2011/1027/7


3. John Baron, MD, MetroHealth Medical Center, 2003-4. Clinical Fellow in Pulmonary & Critical Care Medicine research project.

4. Ziad Shaman, MD, MetroHealth Medical Center, 2004-5. Clinical Fellow in Pulmonary & Critical Care Medicine research project.

5. Amanda Lenhard, MD, MetroHealth Medical Center, 2004-5. Internal Medicine resident research project.

6. Yen-Yuan Chen, Case Western Reserve University School of Medicine, 2005-2007 . Candidate for PhD in Clinical Ethics. Research project supervisor.

7. Brandon Maughan, Case Western Reserve University School of Medicine, 2006-2007. Medical student research under T35 L082544 (Research Training in Heart, Lung, Blood & Sleep Disorders, PI: CM Doerschuk, 2006-2011)

8. Jason Waechter, MD, University of Manitoba Faculty of Medicine, 2009-2010. Critical Care Research Fellow research project.

9. Jessica Spence, University of Manitoba Faculty of Medicine, 2010-2013. Medical student research project.

10. Jennifer Ziegler, University of Manitoba Faculty of Medicine, 2014-15. Medical student research project.

11. Victor Yang, University of Manitoba Faculty of Medicine, 2014-17. Medical student and Internal Medicine resident research project.

12. Andrew Geisheimer, MD, University of Manitoba Faculty of Medicine, 2016-19. Anesthesia resident research project. Winner of 2018 Department of Anesthesia “Best Overall Resident Research Project”.

Supported by a $10,000 research grant from the Department of Anesthesia 13. Kyle Millar, MD, University of Manitoba, 2017-current. Candidate for MSc in Epidemiology.

Research project supervisor. 14. Tammy Pham, B.S., University of Manitoba, 2017-current. Physician Assistant research project

supervisor. 15. Emily Rimmer, M.Sc. Defence Committee, Department Community Health Sciences, University

of Manitoba, August 2, 2018. 16. Jonah Hirshberg, MD, Univeristy of Manitoba Faculty of Medicine, 2019-current. Anesthesia

resident research project. Supported by a $7,5000 research grant from the Department of Anesthesia.

17. Christina Papadimitropolous, MD, Univeristy of Manitoba Faculty of Medicine, 2019-current. Anesthesia resident research project.

Research Funding Summary (non-profit funding agencies only) Total Funding Received (all roles), 1989-2019 $11,816,534 Total Funding Received as Principal Investigator or Co-Principal Investigator $9,091,399

Current Grant Support 1. Manitoba Medical Services Foundation.Allan Garland, co-applicant, Brett Houston, Principal

Investigator. 4/1/2018-3/31/2019; total direct costs $29,613. “Reducing transfusion while preserving Canada’s blood supply: The use and effectiveness of tranexamic acid in major non-cardiac surgical procedures at high-risk of bleeding.”

2. Canadian Frailty Network (a Canadian National Centre of Excellence). Allan Garland, co-Principal Investigator, 4/1/2017-9/31/2020; total direct costs $1,888,556. “Better tArgetting, Better outcomes for frail ELderly patients (BABEL).” Grant#TG2015-15.

Allan Garland, Principal Investigator, sub-project 1: total direct costs $808,555


3. Research Manitoba, Manitoba Centres of Excellence Fund. Allan Garland, Principal Investigator, 7/2017-6/2020; total direct costs $161,711, “Better tArgetting, Better outcomes for frail ELderly patients (BABEL).”

4. Manitoba Health. Allan Garland, Principal Investigator, 4/2016-6/2020; total direct costs $200,000. “Using administrative data to identify individuals at high risk for near-future critical illness.”

5. Canadian Institute for Health Research. Allan Garland, co-investigator; Alison Fox-Robichaud, MD, PhD, Principal Investigator, 1/2019-12/2019; total direct costs $24,970. “Canadian Sepsis Research Network: Improving Care Before, During and After Sepsis”

6. Canadian Institute for Health Research. Allan Garland, Principal Applicant; Alison Fox-Robichaud, MD, PhD, Nominated Principal Applicant, 12/2019-11/2024; total direct costs $5,700,000. “Canadian Sepsis Research Network: Improving Care Before, During and After Sepsis”

Past Grant Support 1. American Lung Association Research Fellowship, Allan Garland Principal Investigator;

7/1/1989 to 6/30/1991; total direct costs $39,000. "Alternative modes of mechanical ventilation." Julian Solway, MD, Sponsor.

2. United States Public Health Service, Individual National Research Service Award, Allan Garland, Principal Investigator; 7/1/1992 to 10/31/1993; total direct costs $39,768. "Sensory nerves and eicosanoids in hyperpnea-induced airway responses". Julian Solway, MD, Sponsor.

3. Robert Wood Johnson University Hospital Supplemental Grant, Allan Garland, Principal Investigator; 7/1/1995 to 6/30/1996; total direct costs $35,000. "Physiology and Treatment of Respiratory Failure in the Intensive Care Unit”.

4. Allied Healthcare Products, Inc., Allan Garland, Principal Investigator; 1995-96; value of donated equipment $4,000. “Effects of Variations in Mechanical Ventilation on Development of Atelectasis during General Anesthesia”.

5. UMDNJ Foundation, Allan Garland, Principal Investigator; 7/1/1996 to 6/30/1998; total direct costs $25,000. “The Role of Physician and Practice Characteristics in Quality of Care for Critically Ill Patients”.

6. National Institutes of Health, Barbara Daly, Principal Investigator; Allan Garland, Co-investigator (5% effort); 8/1/2005 to 7/31/2008; total direct costs $1,302,326. “Communication System for the Chronically Critically Ill”; NIH RO1 NR009841.

7. St. Boniface Hospital & Research Foundation, Allan Garland, Principal Investigator; 10/2008-3/2010; total direct costs $33,469. “Effect of 24 Hour Intensivist Presence on Intensive Care Unit Outcomes”.

8. Canadian Institutes of Health Research; Synthesis Grant: Knowledge Translation (200805KRS-188504-KRS-CEAF-118683) Allan Garland, Co-Principal Investigator, 11/1/2008-6/30/2009; total direct costs $96,672. “Knowledge Synthesis of Implementation Strategies for Critically Ill Patients (The KRITICAL Study)”

9. Manitoba Health. Allan Garland, Principal Investigator, 4/2008-12/2011; total direct costs $200,000. “Population-based Epidemiology and Outcomes of Critical Illness in Manitoba.”

10. University of Manitoba Research Grants Program. Allan Garland, Principal Investigator, 4/2009-12/2010; total direct costs $6,533. “A Canadian Survey of Off-hours Staffing of Intensive Care Units.”

11. Health Sciences Centre Research Foundation; Operating Grant. Allan Garland, Principal Investigator; 9/1/2010-6/30/2012; total direct costs ($15,938) “The interface between chronic inflammatory disease and critical illness”

http://www.saintboniface.ca/english/index.html


12. Health Sciences Centre Research Foundation. Allen Kraut, Principal Investigator; Allan Garland, Co-investigator; 9/1/2009-6/30/2010; total direct costs $12,538. “Characteristics and outcomes of patients leaving hospital against medical advice”.

13. Manitoba Health Research Council; Operating Grant. Clare Ramsey, Principal Investigator; Allan Garland, Co-investigator; 9/1/2009-6/30/2012; total direct costs $13,178. “Characteristics and outcomes of patients leaving hospital against medical advice”.

14. University of Manitoba Research Grants Program. Allan Garland, Principal Investigator, 1/2011-6/2012; total direct costs $7,225. “Determinants of short-term vs. long-term survival in critical illness.”

15. Canadian Institutes of Health Research; Operating Grant. Allan Garland, Co- Investigator, Daren Heyland, Principal Investigator, 4/1/2009-3/31/2012; total direct costs $943,227. “Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians: The REALISTIC 80 Study”

16. Manitoba Health Research Council; Operating Grant. Ruth Ann Marrie, Principal Investigator; Allan Garland, Co-investigator; 7/1/2010-12/31/2012; total direct costs ($27,987) “The interface between chronic inflammatory disease and critical illness”

17. Canadian Frailty Network (National Centre of Excellence). Allan Garland, Principal Investigator, 3/1/2013-12/30/2015; total direct costs $125,807. “Sex differences in admission to intensive care units: the role of social support factors”, 2013-RFP2012-19-07

18. Manitoba Centres of Excellence Fund; Matching Grant Program. Allan Garland, Principal Investigator, 4/1/2013-3/31/2016; total direct costs $20,098. “Sex differences in admission to intensive care units: the role of social support factors”

19. Canadian Institutes of Health Research; Operating Grant. Allan Garland, Co-Principal Investigator, Ruth Ann Marrie, Co-Principal Investigator, 4/1/2012-3/31/2017; total direct costs $183,622. “Critical illness in Inflammatory Bowel Disease, Multiple Sclerosis, and Rheumatoid Arthritis”, MOP-119318

20. Multiple Sclerosis Society of Canada. Allan Garland, Co-Investigator, Ruth Ann Marrie, Principal Investigator, 4/1/2016-3/31/2019; total direct costs: $285,375. Outcome and Management of Acute Myocardial Infarction in Multiple Sclerosis.

21. Research Manitoba/Health Sciences Centre/University of Manitoba College of Medicine, Faculty of Health Sciences; Manitoba Partnership Program Grant. Allan Garland, Principal Investigator, 10/1/2015-9/30/2018; total direct costs: $65,000. Changes in Work and Earnings After Heart Attack, Stroke and Cardiac Arrest.

22. Heart & Stroke Foundation of Canada; Operating Grant. Allan Garland, Principal Investigator, 7/1/2015-6/30/2018; total direct costs: $245,000. “Changes in Work and Earnings After Heart Attack and Stroke”, G-15-0009227

23. Manitoba Medical Services Foundation; Operating Grant. Allan Garland, Co-Investigator, Brett Houston, Principal Investigator, 4/2018-3/2019; total direct costs: $29,613. “Reducing transfusion while preserving Canada’s blood supply: The use and effectiveness of tranexamic acid in major non-cardiac surgical procedures at high-risk of bleeding”.

24. Manitoba Health. Allan Garland, Principal Investigator, 7/2016-6/2019; total direct costs $200,000. “Using administrative data to identify individuals at high risk for near-future critical illness.”

25. Canadian Frailty Network (National Centre of Excellence). Allan Garland, co-Principal Investigator, 4/1/2017-3/30/2020; total direct costs $1,888,556. “Better tArgetting, Better outcomes for frail ELderly patients (BABEL)”, TG2015-24.

26. Research Manitoba. Allan Garland, Principal Investigator, 4/1/2017-3/30/2020; total direct costs $161,711. “Better tArgetting, Better outcomes for frail ELderly patients (BABEL)”

27. Ontario Academic Health Sciences Centres Alternative Funding Plan Innovation Fund. Allan Garland, Collaborator, Bram Roshwerg, MD, MSc, Principal Investigator, 4/1/2017-3/31/2018;


total direct costs $85,921. “A prospective audit of blood test ordering practices in Hamilton-area Intensive Care Units - part of the RUBIC research program (Reducing Unnecessary Blood tests In the Critically Ill).”

Grant Support Applied For

Past Contract Support 1. Bayer Corporation. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1995-

1997. “Prospective, double-blind, placebo-controlled, multicenter, North American study of safety and efficacy of murine monoclonal antibody to tumor necrosis factor (TNF Mab) for the treatment of patients with septic shock. NORASEPT II”. Contract for participation in multicenter drug study.

2. Therapeutic Antibodies, Inc. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1995-1996. “A Phase I, single dose study to determine the safety and pharmacokinetics of affinity purified ovine anti-tumor necrosis factor alpha, Fab, (lyophilized).” Contract for participation in multicenter drug study.

3. Therapeutic Antibodies, Inc. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1996-1997. “A multi-center Phase II, randomized, placebo-controlled trial of affinity purified ovine derived anti-tumor necrosis factor alpha (CytoTAb) in sepsis syndrome”. Contract for participation in multicenter drug study.

4. Carter-Wallace Laboratories. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1995-1997. “Double-blind, randomized, placebo-controlled, parallel-group, multicenter study of the safety and efficacy of intravenous Taurolidine in septic patients.” Contract for participation in multicenter drug study.

5. Eli Lilly & Company. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1996-1998. “Recombinant activated Protein C: A Phase 2 study to determine the safety, pharmacokinetics, and effective dose range and dosing duration for recombinant activated Protein C in severe sepsis”. Contract for participation in multicenter drug study.

6. Transcend Therapeutics, Inc. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1997-1998. “A double-blind, placebo-controlled study to evaluate the safety and efficacy of Procysteine in the treatment of patients with Acute Respiratory Distress Syndrome”. Contract for participation in multicenter drug study.

7. Therapeutic Antibodies, Inc. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1997-1998. “A multi-center, Phase IIb, randomized, placebo-controlled trial of affinity purified, anti-tumor necrosis factor alpha, ovine Fab (CytoTAb) in sepsis syndrome.” Contract for participation in multicenter drug study.

8. Schering-Plough Research Institute. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1997-1998. “A multi-center, randomized, placebo-controlled trial of IL-10 in patients with acute lung injury.” Contract for participation in multicenter drug study.

9. Ortho Biotech, Inc. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 1999-2001. “Efficacy of rhEPO in the critically ill patient: A randomized, double-blind, placebo-controlled trial.” Contract for participation in multicenter drug study.

10. Eli Lilly & Company. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 2000. “Recombinant human activated Protein C (rhAPC). A Phase 3 study to determine the efficacy and safety for recombinant human activated Protein C in severe sepsis”. Contract for participation in multicenter drug study.

11. Alliance Pharmacetical Corporation. Allan Garland Principal Investigator; 2000. “Multicenter, prospective, randomized, controlled pivotal trial for efficacy of partial liquid ventilation with low


and high doses of perflubron in adult patients with acute lung injury”. Contract for participation in multicenter drug study.

12. Chiron Corporation. Harold Paz, Principal Investigator; Allan Garland, Co-investigator; 2000-2001. “Multicenter, Double Blind, Placebo Controlled, Randomized, Phase 3 Study of Tifacogin in Severe Sepsis”. Contract for participation in multicenter drug study.

13. Eli Lilly & Company. Mark Malangoni, Principal Investigator; Allan Garland, Co-investigator; 2003 -2004 . “Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Early Stage Severe Sepsis.” Contract for participation in multicenter drug study

Documents

Allan Garland, MD, MA - University of Manitoba · 2020-04-08 · Allan Garland, MD, MA Page 3 of 31 2000 - 2005 Clinical Associate Professor, Rutgers University College of Nursing,